BCB Bancorp (BCBP) 10-Q 5 May 21 2021 Q1 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	3 Months Ended
	Mar. 31, 2021	May 03, 2021
Document And Entity Information [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Mar. 31, 2021
Document Transition Report	false
Entity File Number	0-50275
Entity Registrant Name	BCB Bancorp, Inc.
Entity Incorporation, State or Country Code	NJ
Entity Tax Identification Number	26-0065262
Entity Address, Address Line One	104-110 Avenue C
Entity Address, City or Town	Bayonne
Entity Address, State or Province	NJ
Entity Address, Postal Zip Code	07002
City Area Code	201
Local Phone Number	823-0700
Title of 12(b) Security	Common Stock, no par value
Security Exchange Name	NASDAQ
Trading Symbol	BCBP
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		17,121,319
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2021
Document Fiscal Period Focus	Q1
Entity Central Index Key	0001228454
Amendment Flag	false

Consolidated Statements of Fina

Consolidated Statements of Financial Condition - USD ($) $ in Thousands	Mar. 31, 2021	Dec. 31, 2020
ASSETS
Cash and amounts due from depository institutions	$ 24,796	$ 23,201
Interest-earning deposits	272,142	238,028
Total cash and cash equivalents	296,938	261,229
Interest-earning time deposits	735	735
Debt securities available for sale	93,582	99,756
Equity investments	18,278	17,717
Loans held for sale	1,147	3,530
Loans receivable, net of allowance for loan losses of $35,477 and $33,639 respectively	2,296,434	2,295,021
Federal Home Loan Bank of New York stock, at cost	8,920	11,324
Premises and equipment, net	14,796	15,272
Accrued interest receivable	12,056	12,924
Other real estate owned	414	414
Deferred income taxes	13,239	12,574
Goodwill and other intangibles	5,472	5,488
Operating lease right-of-use assets	14,328	14,988
Bank-owned life insurance ("BOLI")	70,234	61,033
Other assets	5,887	9,011
Total Assets	2,852,460	2,821,016
LIABILITIES
Non-interest-bearing deposits	454,061	402,100
Interest bearing deposits	1,950,074	1,915,950
Total deposits	2,404,135	2,318,050
FHLB advances	133,298	191,161
Subordinated debentures	37,101	37,042
Operating lease liability	14,589	15,224
Other liabilities	9,883	10,328
Total Liabilities	2,599,006	2,571,805
STOCKHOLDERS' EQUITY
Preferred stock: $0.01 par value, 10,000,000 shares authorized, issued and outstanding 2,596 shares of Series D 4.5%, Series G 6%, and Series H 3.5% (liquidation value $10,000 per share) noncumulative perpetual preferred stock at March 31, 2021 and December 31, 2020
Additional paid-in capital preferred stock	25,723	25,723
Common stock: no par value; 40,000,000 shares authorized; issued 19,620,630 and 19,574,858 at March 31, 2021 and December 31, 2020, respectively, outstanding 17,121,319 shares and 17,107,640 shares, at March 31, 2021 and December 31, 2020, respectively
Additional paid-in capital common stock	192,633	192,276
Retained earnings	62,777	58,335
Accumulated other comprehensive loss	(349)	(205)
Treasury stock, at cost, 2,499,311 and 2,467,218 shares at March 31, 2021 and December 31, 2020, respectively	(27,330)	(26,918)
Total Stockholders' Equity	253,454	249,211
Total Liabilities and Stockholders' Equity	$ 2,852,460	$ 2,821,016

Consolidated Statements of Fi_2

Consolidated Statements of Financial Condition (Parenthetical) - USD ($) $ in Thousands	3 Months Ended	12 Months Ended
	Mar. 31, 2021	Dec. 31, 2020
Loans receivable, allowance for loan losses	$ 35,477	$ 33,639
Preferred stock, par value per share	$ 0.01	$ 0.01
Preferred stock, shares authorized	10,000,000	10,000,000
Preferred stock, shares issued	2,596	2,596
Preferred stock, shares outstanding	2,596	2,596
Common stock, no par value	$ 0	$ 0
Common stock, shares authorized	40,000,000	40,000,000
Common stock, shares issued	19,620,630	19,574,858
Common stock, shares outstanding	17,121,319	17,107,640
Treasury stock, shares	2,499,311	2,467,218
Series D Preferred Stock [Member]
Preferred stock, dividend rate	4.50%	4.50%
Preferred stock, liquidation preference per share	$ 10,000	$ 10,000
Series G Preferred Stock [Member]
Preferred stock, dividend rate	6.00%	6.00%
Preferred stock, liquidation preference per share	$ 10,000	$ 10,000
Series H Preferred Stock [Member]
Preferred stock, dividend rate	3.50%	3.50%
Preferred stock, liquidation preference per share	$ 10,000	$ 10,000

Consolidated Statements of Inco

Consolidated Statements of Income - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Interest and dividend income:
Loans, including fees	$ 26,863	$ 26,814
Mortgage-backed securities	206	563
Other investment securities	784	8
FHLB stock and other interest earning assets	222	2,034
Total interest income	28,075	29,419
Deposits:
Demand	1,198	2,208
Savings and club	118	105
Certificates of deposit	1,992	6,432
Total deposits	3,308	8,745
Borrowings	1,205	1,896
Total interest expense	4,513	10,641
Net interest income	23,562	18,778
Provision for loan losses	1,865	1,500
Net interest income after provision for loan losses	21,697	17,278
Non-interest income:
Fees and service charges	1,111	726
Bank-owned Life Insurance ("BOLI") income	701
Gain on sales of loans	274	61
Realized and unrealized loss on equity investments	(196)	(440)
Other	60	336
Total non-interest income	1,950	683
Non-interest expense:
Salaries and employee benefits	6,545	7,389
Occupancy and equipment	2,953	2,824
Data processing service fees	1,008	938
Professional fees	412	470
Director fees	247	358
Regulatory assessments	376	321
Advertising and promotional	12	61
Other real estate owned, net	4	26
Loss from extinguishment of debt	540
Other	1,486	1,977
Total non-interest expense	13,583	14,364
Income before income tax provision	10,064	3,597
Income tax provision	2,947	1,076
Net Income	7,117	2,521
Preferred stock dividends	283	342
Net Income available to common stockholders	$ 6,834	$ 2,179
Net Income per common share-basic and diluted
Basic	$ 0.40	$ 0.12
Diluted	$ 0.40	$ 0.12
Weighted average number of common shares outstanding
Basic	17,115	17,502
Diluted	17,232	17,551

Consolidated Statements of Comp

Consolidated Statements of Comprehensive Income - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Consolidated Statements of Comprehensive Income [Abstract]
Net Income	$ 7,117	$ 2,521
Unrealized (losses) gains on available-for-sale securities:
Unrealized holding (losses) gains arising during the period	(192)	3,309
Tax Effect	48	(820)
Other comprehensive (loss) income	(144)	2,489
Comprehensive income	$ 6,973	$ 5,010

Consolidated Statement of Chang

Consolidated Statement of Changes in Stockholders' Equity - USD ($) $ in Thousands	Additional Paid-In Capital [Member]	Retained Earnings [Member]	Treasury Stock [Member]	Accumulated Other Comprehensive Income (Loss) [Member]	Total
Beginning balance at Dec. 31, 2019	$ 215,310	$ 48,429	$ (22,048)	$ (2,218)	$ 239,473
Net income		2,521			2,521
Other comprehensive (loss) income				2,489	2,489
Cost for Issuance of common stock	(126)				(126)
Redemption of Series D Preferred Stock	(140)				(140)
Exercise Stock Option Expense (500 shares)	5				5
Stock-based compensation expense	279				279
Treasury stock purchases			(1,287)		(1,287)
Dividends payable on Series C 6%, Series D 4.5%, Series F 6%, Series G 6%, and Series H 3.5% noncumulative perpetual preferred stock		(342)			(342)
Cash dividends on common stock ($0.14 per share declared)		(2,336)			(2,336)
Dividend reinvestment plan	104	(104)
Stock purchase plan	102				102
Ending balance at Mar. 31, 2020	215,534	48,168	(23,335)	271	240,638
Beginning balance at Dec. 31, 2020	217,999	58,335	(26,918)	(205)	249,211
Net income		7,117			7,117
Other comprehensive (loss) income				(144)	(144)
Stock-based compensation expense	135				135
Treasury stock purchases			(412)		(412)
Dividends payable on Series C 6%, Series D 4.5%, Series F 6%, Series G 6%, and Series H 3.5% noncumulative perpetual preferred stock		(283)			(283)
Cash dividends on common stock ($0.14 per share declared)		(2,281)			(2,281)
Dividend reinvestment plan	111	(111)
Stock purchase plan	111				111
Ending balance at Mar. 31, 2021	$ 218,356	$ 62,777	$ (27,330)	$ (349)	$ 253,454

Consolidated Statement of Cha_2

Consolidated Statement of Changes in Stockholders' Equity (Parenthetical) - $ / shares	3 Months Ended		12 Months Ended
	Mar. 31, 2021	Mar. 31, 2020	Dec. 31, 2020
Exercise of stock options (shares)	7,000	500
Cash dividends on common stock (per share)	$ 0.14	$ 0.14
Treasury stock purchases (shares)	32,093	127,058
Series C Preferred Stock [Member]
Preferred stock, dividend rate		6.00%
Series D Preferred Stock [Member]
Preferred stock, dividend rate	4.50%	4.50%	4.50%
Series F Preferred Stock [Member]
Preferred stock, dividend rate		6.00%
Series G Preferred Stock [Member]
Preferred stock, dividend rate	6.00%	6.00%	6.00%
Series H Preferred Stock [Member]
Preferred stock, dividend rate	3.50%	3.50%	3.50%

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Cash Flows from Operating Activities:
Net Income	$ 7,117	$ 2,521
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation of premises and equipment	634	734
Amortization and accretion, net	(191)	(579)
Provision for loan losses	1,865	1,500
Deferred income tax benefit	(617)	(293)
Loans originated for sale	(10,074)	(3,868)
Proceeds from sale of loans	12,731	4,008
Gain on sales of loans originated for sale	(274)	(61)
Realized and unrealized loss on equity investments	196	440
Stock-based compensation expense	135	279
BOLI income	(701)
Decrease (increase) in interest receivable	868	(618)
Decrease (increase) in other assets	3,124	(186)
Decrease in accrued interest payable	(656)	(516)
Increase in other liabilities	211	2,304
Net Cash Provided by Operating Activities	14,368	5,665
Cash flows from Investing Activities:
Proceeds from repayments, calls, and maturities on securities available for sale	5,843	7,413
Purchases of securities	(757)	(7,502)
Proceeds from bulk sale of impaired loans	180
Net (increase) decrease in loans receivable	(2,891)	13,594
Purchases of BOLI	(8,500)
Additions to premises and equipment	(158)	(106)
Redemption (Purchase) of Federal Home Loan Bank of New York stock	2,404	(765)
Net Cash (Used In) Provided by Investing Activities	(3,879)	12,634
Cash flows from Financing Activities:
Net increase in deposits	86,085	13,658
Proceeds from Federal Home Loan Bank of New York advances	10,000	27,000
Repayments of Federal Home Loan Bank of New York Advances	(68,000)	(10,000)
Purchases of treasury stock	(412)	(1,287)
Cash dividends paid on common stock	(2,281)	(2,336)
Cash dividends paid on preferred stock	(283)	(342)
Net proceeds (costs) from issuance of common stock	111	(24)
Net payment on redemption of preferred stock		(140)
Exercise of stock options		5
Net Cash Provided by Financing Activities	25,220	26,534
Net Increase in Cash and Cash Equivalents	35,709	44,833
Cash and Cash Equivalents - Beginning	261,229	550,353
Cash and Cash Equivalents - Ending	296,938	595,186
Supplementary Cash Flow Information:
Cash paid during the year for: Income taxes	375	279
Cash paid during the year for: Interest	$ 5,169	$ 11,157

Basis of Presentation

Basis of Presentation	3 Months Ended
	Mar. 31, 2021
Basis of Presentation [Abstract]
Basis of Presentation	Note 1 – Basis of Presentation The accompanying unaudited consolidated financial statements include the accounts of BCB Bancorp, Inc. (the “Company”) and the Company’s wholly owned subsidiaries, BCB Community Bank (the “Bank”), BCB Holding Company Investment Corporation, Special Asset REO I, LLC., and Special Asset REO II, LLC. The Company’s business is conducted principally through the Bank. All significant intercompany accounts and transactions have been eliminated in consolidation. The accompanying unaudited consolidated financial statements have been prepared in accordance with the instructions to Form 10-Q and Regulation S-X and, therefore, do not necessarily include all information that would be included in audited consolidated financial statements. The information furnished reflects all adjustments that are, in the opinion of management, necessary for a fair presentation of consolidated financial condition and results of operations. All such adjustments are of a normal recurring nature. These results are not necessarily indicative of the results to be expected for the fiscal year ending December 31 , or any other future period. The preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the United States of America (“GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities as of the date of the consolidated statement of financial condition and revenues and expenses for the periods then ended. Actual results could differ significantly from those estimates. These unaudited consolidated financial statements should be read in conjunction with the Company’s audited consolidated financial statements and related notes for the year ended December 31, 2020, which are included in the Company’s Annual Report on Form 10-K as filed with the Securities and Exchange Commission. In preparing these consolidated financial statements, the Company evaluated the events and transactions that occurred between December 31, 2020 and the date these consolidated financial statements were issued. Risks and Uncertainties - We are subject to risks and uncertainties as a result of the ongoing COVID-19 pandemic. The extent of the impact of the COVID-19 pandemic on the Company's business is highly uncertain and difficult to predict. The severity of the impact of the ongoing COVID-19 pandemic on the Company's business will depend on a number of factors, including, but not limited to, the duration and severity of the pandemic and the extent and severity of the impact on the Company's customers and any government or governmental responses thereto, including legislative or regulatory changes as well as the distribution and effectiveness of COVID-19 vaccines, all of which are uncertain and cannot be predicted. The Company's future results of operations and liquidity could be adversely impacted. As of the date of issuance of these condensed consolidated financial statements, the extent to which the COVID-19 pandemic may materially impact the Company's financial condition, liquidity, or results of operations is uncertain.

Recent Accounting Pronouncement

Recent Accounting Pronouncements	3 Months Ended
	Mar. 31, 2021
Recent Accounting Pronouncements [Abstract]
Recent Accounting Pronouncements	Note 2 - Recent Accounting Pronouncements In June 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2016-13, Financial Instruments - Credit Losses ASU 2016-13, and related guidance, requires entities to report “expected” credit losses on financial instruments and other commitments to extend credit rather than the current “incurred loss” model. These expected credit losses for financial assets held at the reporting date are to be based on historical experience, current conditions, and reasonable and supportable forecasts. This ASU will also require enhanced disclosures to help investors and other financial statement users better understand significant estimates and judgments used in estimating credit losses, as well as the credit quality and underwriting standards of an entity’s portfolio. These disclosures include qualitative and quantitative requirements that provide additional information about the amounts recorded in the consolidated financial statements. The amendments are effective for the Company in 2023. The Company has begun evaluating the impact the adoption of ASU 2016-13 will have on its consolidated financial statements and results of operations. The effect of this change cannot be ascertained at this point, and will depend upon factors including asset components, asset quality and market conditions at the adoption date. The Company has created a Current Expected Credit Loss (“CECL”) task group comprised of members of its finance, credit administration, lending, internal audit, loan operations, compliance, and information systems units. The CECL task group has become familiar with the provisions of ASU 2016-13 and is in the process of implementing the new guidance, which includes, but is not limited to: (1) identifying segments and sub-segments within the loan portfolio that have similar risk characteristics; (2) determining the appropriate methodology for each segment; (3) implementing changes that are necessary to its core operating system and interfaces to be able to capture appropriate data requirements; and (4) evaluating qualitative and economic factors to develop appropriate forecasts for integration into the model. The Company is currently evaluating the effect this guidance may have on its operating results and/or financial position, including assessing any potential impact on its capital.

Reclassification

Reclassification	3 Months Ended
	Mar. 31, 2021
Reclassification [Abstract]
Reclassification	Note 3 – Reclassification Certain amounts as of December 31, 2020 and for the three-month period March 31, 2020 have been reclassified to conform to the current period’s presentation. These changes had no effect on the Company’s results of operations or financial position.

Equity Incentive Plans

Equity Incentive Plans	3 Months Ended
	Mar. 31, 2021
Equity Incentive Plans [Abstract]
Equity Incentive Plans	Note 4 – Equity Incentive Plans Equity Incentive Plans The Company, under the plan approved by its shareholders on April 28, 2011 (“2011 Stock Plan”), authorized the issuance of up to 900,000 shares of common stock of the Company pursuant to grants of stock options. Employees and directors of the Company and the Bank are eligible to participate in the 2011 Stock Plan. All stock options will be granted in the form of either "incentive" stock options or "non-qualified" stock options. Incentive stock options have certain tax advantages that must comply with the requirements of Section 422 of the Internal Revenue Code. Only employees are permitted to receive incentive stock options. The Company, under the plan approved by its shareholders on April 26, 2018 (“2018 Equity Incentive Plan”), authorized the issuance of up to 1,000,000 shares of common stock of the Company pursuant to grants of stock options and restricted stock units. Employees and directors of the Company and the Bank are eligible to participate in the 2018 Stock Plan. All stock options will be granted in the form of either "incentive" stock options or "non-qualified" stock options. Incentive stock options have certain tax advantages that must comply with the requirements of Section 422 of the Internal Revenue Code. Only employees are permitted to receive incentive stock options. On February 10, 2021, grants of 66,000 options, in aggregate, were declared for members of the Board of Directors of the Bank and the Company which vest over a 5 -year period, commencing on the first anniversary of the grant date. The exercise price was recorded as of close of business on February 10, 2021. On February 10, 2021, awards of 26,400 shares of restricted stock, in aggregate, were declared for members of the Board of Directors of the Bank and the Company, which vest over a 4 -year period, commencing on the anniversary of the award date. On February 19, 2021, an award of 300 shares of restricted stock was declared for an officer of the Bank and the Company, which vest over a 2 -year period, commencing on the anniversary of the award date. Note 4 – Equity Incentive Plans (Continued) The following table presents a summary of the status of the Company’s restricted shares as of March 31, 2021 and 2020. Number of Shares Awarded Weighted Average Grant Date Fair Value Non-vested at January 1, 2021 22,304 $ 12.46 Granted 26,700 12.89 Vested - - Forfeited - - Non-vested at March 31, 2021 49,004 $ 12.70 Number of Shares Awarded Weighted Average Grant Date Fair Value Non-vested at January 1, 2020 81,278 $ 11.96 Granted - - Vested - - Forfeited - - Non-vested at March 31, 2020 81,278 $ 11.96 Expected future expenses relating to the non-vested restricted shares outstanding as of March 31, 2021 was approximately $ 361,000 over a weighted average period of 3.28 years . The following tables present a summary of the status of the Company’s outstanding stock option awards as of March 31, 2021 and 2020. Number of Option Shares Range of Exercise Prices Weighted Average Exercise Price Outstanding at January 1, 2021 1,192,348 $ 8.93 - 13.32 $ 11.45 Options granted 66,000 12.93 12.93 Options exercised ( 7,000 ) 9.39 9.39 Options forfeited - - - Options expired - - - Outstanding at March 31, 2021 1,251,348 $ 8.93 - 13.32 $ 11.54 As of March 31, 2021, stock options which were granted and were exercisable totaled 824,536 stock options. It is Company policy to issue new shares upon share option exercise. Expected future compensation expense relating to the 426,812 shares of unvested options outstanding as of March 31, 2021 was $ 713,000 over a weighted average period of 4.99 years. Number of Option Shares Range of Exercise Prices Weighted Average Exercise Price Outstanding at January 1, 2020 1,200,975 $ 8.93 - 13.32 $ 11.45 Options granted - - - Options exercised ( 500 ) 10.55 10.55 Options forfeited - - - Options expired - - - Outstanding at March 31, 2020 1,200,475 $ 8.93 - 13.32 $ 11.45 As of March 31, 2020, stock options which were granted and were exercisable totaled 515,800 stock options.

Net Income per Common Share

Net Income per Common Share	3 Months Ended
	Mar. 31, 2021
Net Income per Common Share [Abstract]
Net Income per Common Share	Note 5 – Net Income per Common Share Basic net income per common share is computed by dividing net income less dividends on preferred stock by the weighted average number of shares of common stock outstanding. The diluted net income per common share is computed by adjusting the weighted average number of shares of common stock outstanding to include the effects of outstanding stock options, if dilutive, using the treasury stock method. Dilution is not applicable in periods of net loss. For the three months ended March 31, 2021 and 2020, the difference in the weighted average number of basic and diluted common shares was due solely to the effects of outstanding stock options. No adjustments to net income were necessary in calculating basic and diluted net income per share. For the three months ended March 31, 2021 and 2020, the weighted average number of outstanding options considered to be anti-dilutive were 0 and 687 , respectively. The following is a reconciliation of the numerators and denominators of the basic and diluted earnings per share computations: For the Three Months Ended March 31, 2021 2020 Income Shares Per Share Income Shares Per Share (Numerator) (Denominator) Amount (Numerator) (Denominator) Amount (In Thousands, except per share data) Net income available to common stockholders $ 6,834 $ 2,179 Basic earnings per share: Income available to common stockholders $ 6,834 17,115 $ 0.40 $ 2,179 17,502 $ 0.12 Effect of dilutive securities: Stock options - 117 - 49 Diluted earnings per share: Income available to common stockholders $ 6,834 17,232 $ 0.40 $ 2,179 17,551 $ 0.12

Securities

Securities	3 Months Ended
	Mar. 31, 2021
Securities [Abstract]
Securities	Note 6 - Securities Equity Securities Equity securities are defined to include (a) preferred, common and other ownership interests in entities including partnerships, joint ventures and limited liability companies and (b) rights to acquire or dispose of ownership interest in entities at fixed or determinable prices. The following is a summary of unrealized and realized gains and losses recognized in net income on equity securities during the three-months ended March 31, 2021 and 2020: For the three months ended March 31, (In Thousands) 2021 2020 Net losses recognized during the period on equity securities $ ( 196 ) $ ( 440 ) Less: Net gains recognized during the period on equity securities sold during the period - - Unrealized losses recognized during the reporting period on equity securities still held at the reporting date $ ( 196 ) $ ( 440 ) Debt Securities Available for Sale The following tables present by maturity the amortized cost, gross unrealized gains and losses on, and fair value of, securities available for sale as of March 31, 2021 and December 31, 2020: March 31, 2021 Gross Gross Amortized Unrealized Unrealized Cost Gains Losses Fair Value (In Thousands) Residential Mortgage-backed securities: More than one to five years $ 3,157 $ 2 $ 72 $ 3,087 More than five to ten years 4,429 139 22 4,546 More than ten years 34,995 622 398 35,219 42,581 763 492 42,852 Corporate Debt securities: More than five to ten years 32,280 2,077 25 34,332 Municipal obligations: Less than one year 12,048 - - 12,048 More than ten years 4,183 167 - 4,350 16,231 167 - 16,398 Total securities $ 91,092 $ 3,007 $ 517 $ 93,582 December 31, 2020 Gross Gross Amortized Unrealized Unrealized Cost Gains Losses Fair Value (In Thousands) Residential Mortgage-backed securities: More than one to five years $ 3,208 $ 10 $ 67 $ 3,151 More than five to ten years 4,799 163 - 4,962 More than ten years 40,531 741 60 41,212 Sub-total: 48,538 914 127 49,325 Corporate Debt securities: More than five to ten years 32,279 1,719 13 33,985 Sub-total: 32,279 1,719 13 33,985 Municipal obligations: Due within one year 12,048 - - 12,048 Due after ten years 4,209 189 - 4,398 Sub-total: 16,257 189 - 16,446 Total Debt Securities Available $ 97,074 $ 2,822 $ 140 $ 99,756 The unrealized losses, categorized by the length of time of continuous loss position, and fair value of related securities available for sale were as follows: 12 Months or Less More than 12 Months Total Fair Unrealized Fair Unrealized Fair Unrealized Value Losses Value Losses Value Losses (In Thousands) March 31, 2021 Residential mortgage-backed securities $ 12,221 $ 420 $ 1,263 $ 72 $ 13,484 $ 492 Corporate Debt securities 975 25 - - 975 25 $ 13,196 $ 445 $ 1,263 $ 72 $ 14,459 $ 517 December 31, 2020 Residential mortgage-backed securities $ 6,126 $ 60 $ 1,278 $ 67 $ 7,404 $ 127 Corporate Debt Securities 5,487 13 - - 5,487 13 $ 11,613 $ 73 $ 1,278 $ 67 $ 12,891 $ 140 Management evaluates securities for other-than-temporary impairment (“OTTI”) at least on a quarterly basis, and more frequently when economic or market conditions warrant such evaluation. Consideration is given to (1) the length of time and the extent to which the fair value has been less than cost, (2) the financial condition and near-term prospects of the issuer, and (3) whether the Company intends to sell the security or more likely than not will be required to sell the security before its anticipated recovery. At March 31, 2021 and December 31, 2020, management performed an assessment for possible OTTI of the Company’s residential mortgage-backed securities on an issue-by-issue basis, relying on information obtained from various sources, including publicly available financial data, ratings by external agencies, brokers and other sources. The extent of individual analysis applied to each security depended on the size of the Company’s investment, as well as management’s perception of the credit risk associated with each security. Based on the results of the assessment, management believes impairment of these securities, at March 31, 2021 and December 31, 2020, to be temporary.

Loans Receivable and Allowance

Loans Receivable and Allowance for Loan Losses	3 Months Ended
	Mar. 31, 2021
Loans Receivable and Allowance for Loan Losses [Abstract]
Loans Receivable and Allowance for Loan Losses	Note 7 - Loans Receivable and Allowance for Loan Losses The following tables present the recorded investment in loans receivable as of March 31, 2021 and December 31, 2020 by segment and class: March 31, 2021 December 31, 2020 (In Thousands) Residential one-to-four family $ 234,375 $ 244,369 Commercial and multi-family 1,700,113 1,690,836 Construction 167,224 155,967 Commercial business (1) 177,340 184,357 Home equity (2) 53,360 53,667 Consumer 851 822 2,333,263 2,330,018 Less: Deferred loan fees, net ( 1,352 ) ( 1,358 ) Allowance for loan losses ( 35,477 ) ( 33,639 ) Sub-total ( 36,829 ) ( 34,997 ) Total Loans, net $ 2,296,434 $ 2,295,021 (1) Includes business lines of credit. (2) Includes home equity lines of credit. - Note 7 – Loans Receivable and Allowance for Loan Losses (Continued) Allowance for Loan Losses The allowance for loan loss is evaluated regularly by management and reflects consideration of all significant factors that affect the collectability of the loan portfolio. The Company’s methodology for assessing the adequacy of the allowance for loan losses consists of several key elements. These elements include a general allocated reserve for performing loans, a specific reserve for impaired loans and an unallocated portion. The Company consistently applies the following comprehensive methodology. During the quarterly review of the allowance for loan losses, the Company considers a variety of qualitative factors that include:  Lending Policies and Procedures  Personnel responsible for the particular portfolio - relative to experience and ability of staff  Trend for past due, criticized and classified loans  Relevant economic factors  Quality of the loan review system  Value of collateral for collateral dependent loans  The effect of any concentrations of credit and the changes in the level of such concentrations  Other external factors The methodology includes the segregation of the loan portfolio into two divisions. Loans that are performing and loans that are impaired. Loans which are performing are evaluated by loan class or loan type. The allowance for performing loans is evaluated based on historical loan loss experience with an adjustment for qualitative factors referred to above. Impaired loans are loans which are more than 90 days delinquent, troubled debt restructured, or adversely classified. These loans are individually evaluated for loan loss either by current appraisal, or net present value. Management reviews the overall estimate for feasibility and establishes the loan loss provision accordingly. Loan categories for specific business types were stressed due to rising delinquencies within those market sectors (hospitality, restaurants, office space, and commercial condos) to determine the potential for collateral shortfalls. The loan portfolio is segmented into the following loan segments, where the risk level for each class is analyzed when determining the allowance for loan losses: Residential one-to-four family real estate loans involve certain risks such as interest rate risk and risk of non-repayment. Adjustable-rate residential real estate loans decrease the interest rate risk to the Bank that is associated with changes in interest rates but involve other risks, primarily because as interest rates rise, the payment by the borrower rises to the extent permitted by the terms of the loan, thereby increasing the potential for default. At the same time, the marketability of the underlying properties may be adversely affected by higher interest rates. Repayment risk may be affected by a number of factors including, but not necessarily limited to, job loss, divorce, illness and personal bankruptcy of the borrower. Commercial and multi-family real estate lending entails additional risks as compared with residential family property lending. Such loans typically involve large loan balances to single borrowers or groups of related borrowers. The payment experience on such loans is typically dependent on the successful operation of the real estate project. The success of such projects is sensitive to changes in supply and demand conditions in the market for commercial real estate as well as economic conditions generally. Construction lending is generally considered to involve a high risk due to the concentration of principal in a limited number of loans and borrowers and the effects of the general economic conditions on developers and builders. Moreover, a construction loan can involve additional risks because of the inherent difficulty in estimating both a property’s value at completion of the project and the estimated cost (including interest) of the project. The nature of these loans is such that they are generally difficult to evaluate and monitor. In addition, speculative construction loans to a builder are not necessarily pre-sold and thus pose a greater potential risk to the Bank than construction loans to individuals on their personal residence. Commercial business lending, including lines of credit, is generally considered higher risk due to the concentration of principal in a limited number of loans and borrowers and the effects of general economic conditions on the business. Commercial business loans are primarily secured by inventories and other business assets. In many cases, any repossessed collateral for a defaulted commercial business loans will not provide an adequate source of repayment of the outstanding loan balance. Home equity lending entails certain risks such as interest rate risk and risk of non-repayment. The marketability of the underlying property may be adversely affected by higher interest rates, decreasing the collateral value securing the loan. Repayment risk can be affected by job loss, divorce, illness and personal bankruptcy of the borrower. Home equity line of credit lending entails securing an equity interest in the borrower’s home. In many cases, the Bank’s position in these loans is as a junior lien holder to another institution’s superior lien. This type of lending is often priced on an adjustable rate basis with the rate set at or above a predefined index. Adjustable-rate loans decrease the interest rate risk to the Bank that is associated with changes in interest rates but involve other risks, primarily because as interest rates rise, the payment by the borrower rises to the extent permitted by the terms of the loan, thereby increasing the potential for default. Consumer loans generally have more credit risk because of the type and nature of the collateral and, in certain cases, the absence of collateral. Consumer loans generally have shorter terms and higher interest rates than other lending. In addition, consumer lending collections are dependent on the borrower’s continuing financial stability, and thus are more likely to be adversely affected by job loss, divorce, illness, and personal bankruptcy. In many cases, any repossessed collateral for a defaulted consumer loan will not provide an adequate source of repayment of the outstanding loan. An unallocated component is maintained to cover uncertainties that could affect management’s estimates of probable losses. The unallocated component of the allowance reflects the margin of imprecision inherent in underlying assumptions used in the methodologies for estimating allocated and general reserves in the portfolio. Note 7 - Loans Receivable and Allowance for Loan Losses (Continued) The following table sets forth the activity in the Company’s allowance for loan losses for the three months ended March 31, 2021, and the related portion of the allowances for loan losses that is allocated to each loan class, as of March 31, 2021 (in thousands): Residential Commercial & Multi-family Construction Commercial Business (1) Home Equity (2) Consumer Unallocated Total Allowance for loan losses: Beginning Balance, January 1, 2021 $ 3,293 $ 21,772 $ 1,977 $ 6,306 $ 286 $ - $ 5 $ 33,639 Charge-offs: ( 57 ) - - - - - - ( 57 ) Recovery: 27 - - - 3 - - 30 Provisions: ( 426 ) 1,347 25 275 4 - 640 1,865 Ending Balance, March 31, 2021: 2,837 23,119 2,002 6,581 293 - 645 35,477 Ending Balance attributable to loans: Individually evaluated for impairment 302 381 - 4,601 23 - - 5,307 Collectively evaluated for impairment 2,535 22,738 2,002 1,980 270 - 645 30,170 Ending Balance, March 31, 2021 2,837 23,119 2,002 6,581 293 - 645 35,477 Loans Receivables: Individually evaluated for impairment 5,509 44,086 2,787 13,269 1,693 - - 67,344 Collectively evaluated for impairment 228,866 1,656,027 164,437 164,071 51,667 851 - 2,265,919 Total Gross Loans: $ 234,375 $ 1,700,113 $ 167,224 $ 177,340 $ 53,360 $ 851 $ - $ 2,333,263 (1) Includes business lines of credit. (2) Includes home equity lines of credit. The following table sets forth the activity in the Company’s allowance for loan losses for the three months ended March 31, 2020 (in thousands): Residential Commercial & Multi-family Construction Commercial Business (1) Home Equity (2) Consumer Unallocated Total Allowance for loan losses: Beginning Balance, January 1, 2020 $ 2,722 $ 15,372 $ 1,244 $ 3,790 $ 333 - $ - $ 273 $ 23,734 Charge-offs: ( 4 ) - - - - - - ( 4 ) Recovery: - - - 302 2 - - 304 Provisions: 413 ( 423 ) ( 139 ) ( 135 ) 290 5 1,489 1,500 Ending Balance March 31, 2020 3,131 14,949 1,105 3,957 625 5 1,762 25,534 Ending Balance attributable to loans: Individually evaluated for impairment 354 332 - 2,524 22 - - 3,232 Collectively evaluated for impairment 2,777 14,617 1,105 1,433 603 5 1,762 22,302 Ending Balance March 31, 2020 3,131 14,949 1,105 3,957 625 5 1,762 25,534 Loans Receivables: Individually evaluated for impairment 8,335 9,895 - 3,466 1,326 - - 23,022 Collectively evaluated for impairment 259,802 1,567,921 101,692 173,680 63,531 1,029 - 2,167,655 Total Gross Loans: $ 268,137 $ 1,577,816 $ 101,692 $ 177,146 $ 64,857 $ 1,029 $ - $ 2,190,677 _____________________________ (1) Includes business lines of credit. (2) Includes home equity lines of credit. Note 7 - Loans Receivable and Allowance for Loan Losses (Continued) The following table sets forth the amount recorded in loans receivable at December 31, 2020. The table also details the amount of total loans receivable that are evaluated individually, and collectively, for impairment and the related portion of the allowance for loan losses that is allocated to each loan class (in thousands): Residential Commercial & Multi-family Construction Commercial Business (1) Home Equity (2) Consumer Unallocated Total Allowance for credit losses: Ending Balance attributable to loans: Individually evaluated for impairment $ 416 $ 378 $ - $ 3,640 $ 27 $ - $ - $ 4,461 Collectively evaluated for impairment 2,877 21,394 1,977 2,666 259 - 5 29,178 Ending Balance, December 31, 2020 $ 3,293 $ 21,772 $ 1,977 $ 6,306 $ 286 $ - $ 5 $ 33,639 Loans Receivables: - Individually evaluated for impairment $ 7,281 $ 61,854 $ - $ 12,492 $ 1,574 $ - $ - $ 83,201 Collectively evaluated for impairment 237,088 1,628,982 155,967 171,865 52,093 822 - 2,246,817 Total Gross Loans: $ 244,369 $ 1,690,836 $ 155,967 $ 184,357 $ 53,667 $ 822 $ - $ 2,330,018 (1) Includes business lines of credit. (2) Includes home equity lines of credit. Note 7 - Loans Receivable and Allowance for Loan Losses (Continued) The following table summarizes the average recorded investment and interest income recognized on impaired loans with no related allowance recorded by portfolio class for the three months ended March 31, 2021 and 2020 (in thousands): Three Months Ended March 31, 2021 2021 2020 2020 Average Interest Average Interest Recorded Income Recorded Income Investment Recognized Investment Recognized Loans with no related allowance recorded: Residential one-to-four family $ 3,453 $ 34 $ 4,656 $ 52 Commercial and Multi-family 44,958 282 10,322 99 Construction 1,394 36 - - Commercial business (1) 5,171 13 2,013 43 Home equity (2) 1,196 10 848 9 Total Impaired Loans with no allowance recorded: $ 56,172 $ 375 $ 17,839 $ 203 Loans with an allowance recorded: Residential one-to-four family $ 2,943 $ 32 $ 3,741 $ 41 Commercial and Multi-family 8,013 129 1,241 20 Commercial business (1) 7,710 93 1,690 3 Home equity (2) 438 2 460 4 Consumer - - - - Total Impaired Loans with an allowance recorded: $ 19,104 $ 256 $ 7,132 $ 68 Total Impaired Loans: $ 75,276 $ 631 $ 24,971 $ 271 __________ (1) Includes business lines of credit. (2) Includes home equity lines of credit. (3) Does not include accretable yield on loans acquired with deteriorated credit. The following table summarizes the recorded investment by portfolio class at March 31, 2021 and December 31, 2020. (in thousands): As of March 31, 2021 As of December 31, 2020 Recorded Unpaid Principal Related Recorded Unpaid Principal Related Investment Balance Allowance Investment Balance Allowance Loans with no related allowance recorded: Residential one-to-four family $ 2,821 $ 3,210 $ - $ 4,084 $ 4,660 $ - Commercial and multi-family 32,357 33,761 - 57,558 58,739 - Construction 2,787 2,787 - - - - Commercial business (1) 4,498 12,573 - 5,844 17,687 - Home equity (2) 1,268 1,270 - 1,124 1,126 - Total Impaired Loans with no related allowance recorded: $ 43,731 $ 53,601 $ - $ 68,610 $ 82,212 $ - Loans with an allowance recorded: Residential one-to-four family $ 2,688 $ 2,723 $ 302 $ 3,197 $ 3,252 $ 416 Commercial and Multi-family 11,729 15,584 381 4,296 4,501 378 Commercial business (1) 8,771 20,662 4,601 6,648 12,511 3,640 Home equity (2) 425 425 23 450 458 27 Total Impaired Loans with an allowance recorded: $ 23,613 $ 39,394 $ 5,307 $ 14,591 $ 20,722 $ 4,461 Total Impaired Loans: $ 67,344 $ 92,995 $ 5,307 $ 83,201 $ 102,934 $ 4,461 __________ (1) Includes business lines of credit. (2) Includes home equity lines of credit. Note 7 - Loans Receivable and Allowance for Loan Losses (Continued) A troubled debt restructured loan (“TDR”) is a loan that has been modified whereby the Company has agreed to make certain concessions to a borrower to meet the needs of both the borrower and the Company to maximize the ultimate recovery of a loan. A TDR occurs when a borrower is experiencing, or is expected to experience, financial difficulties and the loan is modified using a concession that would otherwise not be granted to the borrower. Pursuant to the CARES Act, a loan that was current at December 31, 2019 and modified due to the COVID-19 pandemic is not considered a TDR. The types of concessions granted generally include, but are not limited to, interest rate reductions, limitations on the accrued interest charged, term extensions, and deferment of principal. All TDRs were considered impaired and therefore were individually evaluated for impairment in the calculation of the allowance for loan losses. Prior to their classification as TDRs, certain of these loans had been collectively evaluated for impairment in the calculation of the allowance for loan losses. At March 31,2021 At December 31, 2020 (In thousands) Recorded investment in TDRs: Accrual status $ 13,474 $ 13,760 Non-accrual status 1,074 2,303 Total recorded investment in TDRs $ 14,548 $ 16,063 The Company originated one TDR loan totaling $ 96,532 and one TDR loan totaling $ 216,102 for the three months ended March 31, 2021 and March 31, 2020, respectively. For the three months ended March 31, 2021 and March 31, 2020, TDRs, for which there was a payment default within twelve months of restructuring, totaled $ 127,449 for one loan and $ 0 , respectively. The following table sets forth the delinquency status of total loans receivable as of March 31, 2021: Loans Receivable 30-59 Days 60-90 Days Greater Than Total Past Total Loans >90 Days Past Due Past Due 90 Days Due Current Receivable and Accruing (In Thousands) Residential one-to-four family $ 936 $ - $ 227 $ 1,163 $ 233,212 $ 234,375 $ - Commercial and multi-family 13,148 4,410 2,447 20,005 1,680,108 1,700,113 - Construction 2,787 - - 2,787 164,437 167,224 - Commercial business (1) 457 1,153 4,796 6,406 170,934 177,340 - Home equity (2) 235 39 427 701 52,659 53,360 - Consumer - - - - 851 851 - Total $ 17,563 $ 5,602 $ 7,897 $ 31,062 $ 2,302,201 $ 2,333,263 $ - _________ (1) Includes business lines of credit. (2) Includes home equity lines of credit. The following table sets forth the delinquency status of total loans receivable at December 31, 2020: Loans Receivable 30-59 Days 60-90 Days Greater Than Total Past Total Loans >90 Days Past Due Past Due 90 Days Due Current Receivable and Accruing (In Thousands) Originated loans: Residential one-to-four family $ 507 $ 266 $ 664 $ 1,437 $ 242,932 $ 244,369 $ 125 Commercial and multi-family 15,910 2,996 1,334 20,240 1,670,596 1,690,836 - Construction - - - - 155,967 155,967 - Commercial business (1) 3,889 904 3,354 8,147 176,210 184,357 133 Home equity (2) 541 12 502 1,055 52,612 53,667 75 Consumer - - - - 822 822 - Total $ 20,847 $ 4,178 $ 5,854 $ 30,879 $ 2,299,139 $ 2,330,018 $ 333 (1) Includes business lines of credit. (2) Includes home equity lines of credit. Note 7 - Loans Receivable and Allowance for Loan Losses (Continued) The table below sets forth the amounts and types of non-accrual loans in the Bank’s loan portfolio at March 31, 2021 and December 31, 2020, respectively. Loans are placed on non-accrual status when they become more than 90 days delinquent, or when the collection of principal and/or interest become doubtful. As of March 31, 2021, and December 31, 2020, non-accrual loans differed from the amount of total loans past due greater than 90 days due to loans which are maintained on non-accrual status for a minimum of six months until the borrower has demonstrated its ability to satisfy the terms of the restructured loan. There were $ 7.3 million at March 31, 2021 and $ 11.9 million at December 31, 2020 in nonaccrual loans that were less than ninety days past due. Nonaccrual loans do not include loans acquired with deteriorated credit quality which were recorded at their fair value at acquisition and totaled $ 884,000 at March 31, 2021 and $ 1.1 million at December 31, 2020. As of March 31, 2021 As of December 31, 2020 (In Thousands) (In Thousands) Non-Accruing Loans: Originated loans: Residential one-to-four family $ 701 $ 1,736 Commercial and multi-family 7,962 8,721 Commercial business (1) 5,307 5,383 Home equity (2) 435 556 Total $ 14,405 $ 16,396 _________ (1) Includes business lines of credit. (2) Includes home equity lines of credit. Had non-accrual loans been performing in accordance with their original terms, the interest income recognized for the three months ended March 31, 2021 and December 31, 2020 would have been approximately $ 343,000 and $ 1.5 million, respectively. The Bank has not committed to lend additional funds to the borrowers whose loans have been placed on nonaccrual status. At March 31, 2021 and December 31, 2020, there were $ 0 and $ 333,000 , respectively, of loans which were more than ninety days past due and still accruing interest. Note 7 - Loans Receivable and Allowance for Loan Losses (Continued) Criticized and Classified Assets Company policies provide for a classification system for problem assets. Under this classification system, problem assets are classified as “substandard,” “doubtful,” or “loss.” When the Company classifies problem assets, the Company may establish general allowances for loan losses in an amount deemed prudent by management. General allowances represent loss allowances which have been established to recognize the inherent risk associated with lending activities, but which, unlike specific allowances, have not been allocated to particular problem assets. A portion of general loss allowances established to cover possible losses related to assets classified as substandard or doubtful may be included in determining our regulatory capital. Specific valuation allowances for loan losses generally do not qualify as regulatory capital. The loans classified as substandard are secured either by residential real estate, commercial real estate or heavy equipment. The loans that have been classified substandard were classified as such primarily due to payment status, because updated financial information has not been timely provided, or the collateral underlying the loan is in the process of being revalued. The Company’s internal credit risk grades are based on the definitions currently utilized by the banking regulatory agencies. The grades assigned and definitions are as follows, and loans graded excellent, above average, good and watch list (risk ratings 1-5) are treated as “pass” for grading purposes. The “criticized” risk rating (6) and the “classified” risk ratings (7-9) are detailed below: 6 – Special Mention- Loans currently performing but with potential weaknesses including adverse trends in borrower’s operations, credit quality, financial strength, or possible collateral deficiency. 7 – Substandard - Loans that are inadequately protected by current sound worth, paying capacity, and collateral support. Loans on “nonaccrual” status. The loan needs special and corrective attention. 8 – Doubtful - Weaknesses in credit quality and collateral support make full collection improbable, but pending reasonable factors remain sufficient to defer the loss status. 9 – Loss - Continuance as a bankable asset is not warranted. However, this does not preclude future attempts at partial recovery. The following table presents the loan portfolio types summarized by the aggregate pass rating and the classified ratings of special mention and substandard within the Company’s internal risk rating system as of March 31, 2021 (in thousands). As of March 31, 2021, the Company had no loans with the classified rating of doubtful or loss. Pass Special Mention Substandard Total Residential one-to-four family $ 232,669 $ 724 $ 982 $ 234,375 Commercial and multi-family 1,622,917 38,464 38,732 1,700,113 Construction 164,437 - 2,787 167,224 Commercial business (1) 162,408 1,998 12,934 177,340 Home equity (2) 52,617 - 743 53,360 Consumer 851 - - 851 Total Gross Loans $ 2,235,899 $ 41,186 $ 56,178 $ 2,333,263 _________ (1) Includes business lines of credit and PPP loans. (2) Includes home equity lines of credit. Note 7 - Loans Receivable and Allowance for Loan Losses The following table presents the loan portfolio types summarized by the aggregate pass rating and the classified ratings of special mention and substandard within the Company’s internal risk rating system as of December 31, 2020 (In thousands). As of December 31, 2020, the Company had no loans with the classified rating of doubtful or loss. Pass Special Mention Substandard Total Residential one-to-four family $ 241,237 $ 1,087 $ 2,045 $ 244,369 Commercial and multi-family 1,631,838 2,152 56,846 1,690,836 Construction 155,967 - - 155,967 Commercial business (1) 173,833 1,497 9,027 184,357 Home equity (2) 53,005 - 662 53,667 Consumer 822 - - 822 Total Gross Loans $ 2,256,702 $ 4,736 $ 68,580 $ 2,330,018 ________ (1) Includes business lines of credit. (2) Includes home equity lines of credit.

Stockholders' Equity

Stockholders' Equity	3 Months Ended
	Mar. 31, 2021
Stockholders' Equity [Abstract]
Stockholders' Equity	Note 8 – Stockholders’ Equity On December 15, 2020, the Company closed a private placement of its Series H 3.5 % Noncumulative Perpetual Preferred Stock, resulting in gross proceeds of $ 2,250,000 for 225 shares. On September 1, 2020, the Company closed a private placement of its Series H 3.5 % Noncumulative Perpetual Preferred Stock, resulting in gross proceeds of $ 5.9 million for 590 shares. On August 31, 2020, the Company redeemed all 6,465 outstanding shares of its Series F 6.0 % Noncumulative Perpetual Preferred Stock, at their face value of $ 1,000 per share, for a total redemption amount of $ 6.5 million. On August 10, 2020, the Company redeemed all 388 outstanding shares of its Series C 6.0 % Noncumulative Perpetual Preferred Stock, at their face value of $ 10,000 per share, for a total redemption amount of $ 3.9 million. On July 13, 2020, the Company closed a private placement of its Series H 3.5 % Noncumulative Perpetual Preferred Stock, resulting in gross proceeds of $ 3.1 million for 308 shares, effective June 29, 2020.

Bank Owned Life Insurance

Bank Owned Life Insurance	3 Months Ended
	Mar. 31, 2021
Bank Owned Life Insurance [Abstract]
Bank Owned Life Insurance	Note 9 – Bank Owned Life Insurance The Bank purchased $ 60 million of bank owned life insurance (“BOLI”) in August, 2020 and an additional $ 8.5 million in January, 2021. BOLI involves life insurance purchased by the Bank on a chosen group of employees, and the Bank is owner and beneficiary of the policies. At March 31, 2021, the Bank had $ 70.2 million in BOLI. BOLI is accounted for using the cash surrender value method and is recorded at its net realizable value.

Goodwill and Other Intangible A

Goodwill and Other Intangible Assets	3 Months Ended
	Mar. 31, 2021
Goodwill and Other Intangible Assets [Abstract]
Goodwill and Other Intangible Assets	Note 10 – Goodwill and Other Intangible Assets The Company’s intangible assets consist of goodwill and core deposit intangibles in connection with the acquisition of IA Bancorp, Inc. as of April 17, 2018. The initial recording of goodwill and other intangible assets requires subjective judgments concerning estimates of the fair value of the acquired assets and assumed liabilities. Goodwill is not amortized but is subject to annual tests for impairment or more often if events or circumstances indicate it may be impaired. The Company’s core deposit intangibles are amortized on an accelerated basis using an estimated life of 10 years and in accordance with U.S. GAAP are evaluated annually for impairment. An impairment loss will be recognized if the carrying amount of the intangible asset is not recoverable and exceeds fair value. The carrying amount of the intangible asset is not considered recoverable if it exceeds the sum of the undiscounted cash flows expected to result from the use of the asset. The Company believes that the fair values of our goodwill and other intangible assets were in excess of their carrying amounts and there was no impairment at March 31, 2021. Amortization expense of the core deposit intangibles was $ 16,000 and $ 18,000 for the three months ended March 31, 2021 and 2020 respectively. The unamortized balance of the core deposit intangibles and the amount of goodwill at March 31, 2021 was $ 219,000 and $ 5.2 million, respectively. The unamortized balance of the core-deposit intangibles and the amount of goodwill at March 31, 2020 was $ 281,000 and $ 5.2 million, respectively.

Fair Values of Financial Instru

Fair Values of Financial Instruments	3 Months Ended
	Mar. 31, 2021
Fair Values of Financial Instruments [Abstract]
Fair Values of Financial Instruments	Note 11 – Fair Values of Financial Instruments Guidance on fair value measurements establishes a fair value hierarchy that prioritizes the inputs to valuation methods used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets and liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). The three levels of the fair value hierarchy are as follows: Level 1 : Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities. Level 2 : Quoted prices in markets that are not active, or inputs that are observable either directly or indirectly, for substantially the full term of the asset or liability. Level 3 : Prices or valuation techniques that require inputs that are both significant to the fair value measurement and unobservable (i.e. supported with little or no market activity). An asset or liability’s level within the fair value hierarchy is based on the lowest level of input that is significant to the fair value measurement. The only assets or liabilities that the Company measured at fair value on a recurring basis were as follows. (In thousands): (Level 1) (Level 2) Quoted Prices in Significant (Level 3) Active Markets Other Significant for Identical Observable Unobservable Description Total Assets Inputs Inputs As of March 31, 2021: Securities Debt Securities Available for Sale $ 93,582 $ - $ 93,582 $ - Marketable Equities $ 18,278 $ 18,278 $ - $ - Total Securities $ 111,860 $ 18,278 $ 93,582 $ - As of December 31, 2020: Securities Debt Securities Available for Sale $ 99,756 $ - $ 99,756 $ - Marketable Equities $ 17,717 $ 17,717 $ - $ - Total Securities $ 117,473 $ 17,717 $ 99,756 $ - The Company’s policy is to recognize transfers between levels as of the actual date of the event or change in circumstances that caused the transfer. There were no transfers of assets or liabilities into or out of Level 1, Level 2, or Level 3 of the fair value hierarchy during the three months ended March 31, 2021 and 2020. The only assets or liabilities that the Company measured at fair value on a nonrecurring basis were as follows. (In thousands): (Level 1) (Level 2) Quoted Prices in Significant (Level 3) Active Markets Other Significant for Identical Observable Unobservable Description Total Assets Inputs Inputs As of March 31, 2021 Impaired Loans $ 18,306 $ - $ - $ 18,306 Other real estate owned $ 414 $ - $ - $ 414 As of December 31, 2020: Impaired Loans $ 10,130 $ - $ - $ 10,130 Other real estate owned $ 414 $ - $ - $ 414 Note 11 – Fair Values of Financial Instruments (Continued) The following tables present additional quantitative information as of March 31, 2021 and December 31, 2020 about assets measured at fair value on a nonrecurring basis and for which the Company has utilized adjusted Level 3 inputs to determine fair value. (Dollars in thousands): Quantitative Information about Level 3 Fair Value Measurements Fair Value Valuation Unobservable Estimate Techniques Input Range March 31, 2021: Impaired Loans $ 18,306 Appraisal of collateral (1) Appraisal adjustments (2) 0 %- 10 % Other real estate owned $ 414 Appraisal of collateral (1) Appraisal adjustments (2) 0 %- 10 % Fair Value Valuation Unobservable Estimate Techniques Input Range December 31, 2020: Impaired Loans $ 10,130 Appraisal of collateral (1) Appraisal adjustments (2) 0 %- 10 % Other real estate owned $ 414 Appraisal of collateral (1) Appraisal adjustments (2) 0 %- 10 % (1) Fair value is generally determined through independent appraisals of the underlying collateral, which generally include various level 3 inputs which are not objectively determinable. (2) Appraisals may be adjusted by management for qualitative factors such as economic conditions and estimated liquidation expenses. The range of liquidation expenses and other appraisal adjustments are presented as a percent of the appraisal. The following information should not be interpreted as an estimate of the fair value of the entire Company since a fair value calculation is only provided for a limited portion of the Company’s assets and liabilities. Due to a wide range of valuation techniques and the degree of subjectivity used in making the estimates, comparisons between the Company’s disclosures and those of other companies may not be meaningful. The following methods and assumptions were used to estimate the fair values of the Company’s financial instruments as of March 31, 2021 and December 31, 2020. Cash and Cash Equivalents and Interest-Earning Time Deposits (Carried at Cost) The carrying amounts reported in the consolidated statements of financial condition for cash and short-term instruments approximate fair values. Securities Available for Sale The fair value of securities available for sale (carried at fair value) are determined by matrix pricing (Level 2), which is a mathematical technique used widely in the industry to value debt securities without relying exclusively on quoted market prices for the specific securities but rather by relying on the securities’ relationship to other benchmark quoted prices. Equity Securities The fair values of available-for-sale securities are based on quoted market prices (Level 1). Loans Held for Sale (Carried at Lower of Cost or Fair Value) The fair value of loans held for sale is determined, when possible, using quoted secondary-market prices. If no such quoted prices exist, the fair value of a loan is determined using quoted prices for a similar loan or loans, adjusted for specific attributes of that loan. Loans held for sale are carried at the lower of cost or fair value. Loans Receivable (Carried at Cost) The fair values of loans, except for certain impaired loans, are estimated using discounted cash flow analyses, using market rates at the date of the Statement of Financial Condition that reflect the credit and interest rate-risk inherent in the loans. Projected future cash flows are calculated based upon contractual maturity or call dates, projected repayments and prepayments of principal. Generally, for variable rate loans that reprice frequently and with no significant change in credit risk, fair values are based on carrying values. Note 11 – Fair Values of Financial Instruments (Continued) Impaired Loans (Generally Carried at Fair Value) Impaired loans are those for which the Company has measured and recorded an impairment generally based on the fair value of the loan’s collateral, less estimated costs to sell. Fair value is generally determined based upon independent third-party appraisals of the properties, or discounted cash flows based upon the expected proceeds. These assets are included as Level 3 fair values, based upon the lowest level of input that is significant to the fair value measurements. The fair value at March 31, 2021 and December 31, 2020 consisted of the loan balances of $ 23.6 million net of a valuation allowance of $ 5.3 million and $ 14.6 million net of a valuation of loan allowance of $ 4.4 million, respectively. Other Real Estate Owned (Generally Carried at Lower of Cost or Fair Value) Real Estate Owned is generally carried at fair value less estimated costs to sell which is determined based upon independent third-party appraisals of the properties or based upon the expected proceeds from a pending sale. These assets are included as Level 3 fair values, based upon the lowest level of input that is significant to the fair value measurements. FHLB of New York Stock (Carried at Cost) The carrying amount of restricted investment in bank stock approximates fair value and considers the limited marketability of such securities. Interest Receivable and Payable (Carried at Cost) The carrying amount of interest receivable and interest payable approximates its fair value. Deposits (Carried at Cost) The fair values disclosed for demand deposits (e.g., interest and non-interest checking, passbook savings and money market accounts) are, by definition, equal to the amount payable on demand at the reporting date (i.e., their carrying amounts). Fair values for fixed-rate certificates of deposit are estimated using a discounted cash flow calculation that applies interest rates currently being offered in the market on certificates to a schedule of aggregated expected monthly maturities on time deposits. Borrowings and Subordinated Debt (Carried at Cost) Fair values are estimated using discounted cash flow analysis, based on quoted prices for new long-term debt with similar credit risk characteristics, terms and remaining maturity. Prices obtained from this active market represent a market value that is deemed to represent the transfer price if the liability were assumed by a third party. Off-Balance Sheet Financial Instruments (Carried at Cost) Fair values for the Company’s off-balance sheet financial instruments (lending commitments and unused lines of credit) are based on fees currently charged in the market to enter into similar agreements, taking into account, the remaining terms of the agreements and the counterparties’ credit standing. The fair value of these commitments was deemed immaterial and is not presented in the accompanying table. Note 11 – Fair Values of Financial Instruments (Continued) The carrying values and estimated fair values of financial instruments were as follows as of March 31, 2021 and December 31, 2020: As of March 31, 2021 Quoted Prices in Active Significant Significant Carrying Markets for Identical Assets Other Observable Inputs Unobservable Inputs Value Fair Value (Level 1) (Level 2) (Level 3) (In Thousands) Financial assets: Cash and cash equivalents $ 296,938 $ 296,938 $ 296,938 $ - $ - Interest-earning time deposits 735 735 - 735 - Debt securities available for sale 93,582 93,582 - 93,582 - Equity investments 18,278 18,278 18,278 - - Loans held for sale 1,147 1,147 - 1,147 - Loans receivable, net 2,296,434 2,294,631 - - 2,294,631 FHLB of New York stock, at cost 8,920 8,920 - 8,920 - Accrued interest receivable 12,056 12,056 - 12,056 - Other Real Estate Owned 414 414 - - 414 Financial liabilities: Deposits 2,404,135 2,408,469 1,719,149 689,320 - Borrowings 133,298 131,806 - 131,806 - Subordinated debentures 37,101 36,686 - 36,686 - Accrued interest payable 807 807 - 807 - As of December 31, 2020 Quoted Prices in Active Significant Significant Carrying Markets for Identical Assets Other Observable Inputs Unobservable Inputs Value Fair Value (Level 1) (Level 2) (Level 3) (In Thousands) Financial assets: Cash and cash equivalents $ 261,229 $ 261,229 $ 261,229 $ - $ - Interest-earning time deposits 735 735 - 735 - Debt securities available for sale 99,756 99,756 - 99,756 - Equity investments 17,717 17,717 17,717 - - Loans held for sale 3,530 3,530 - 3,530 - Loans receivable, net 2,295,021 2,309,118 - - 2,309,118 FHLB of New York stock, at cost 11,324 11,324 - 11,324 - Accrued interest receivable 12,924 12,924 - 12,924 - Other Real Estate Owned - - - - - Financial liabilities: Deposits 2,318,050 2,323,561 1,627,871 695,690 - Borrowings 191,161 194,899 - 194,899 - Subordinated debentures 37,042 37,252 - 37,252 - Accrued interest payable 1,463 1,463 - 1,463 -

Subordinated Debt

Subordinated Debt	3 Months Ended
	Mar. 31, 2021
Subordinated Debt [Abstract]
Subordinated Debt	Note 12 – Subordinated debt On July 30, 2018, the Company issued $ 33.5 million of fixed-to-floating rate subordinated debentures (the “Notes”) in a private placement. The Notes have a ten-year term and bear interest at a fixed annual rate of 5.625 % for the first five years of the term (the "Fixed Interest Rate Period"). From and including August 1, 2023, the interest rate will adjust to a floating rate based on the three-month LIBOR plus 2.72 % until redemption or maturity (the "Floating Interest Rate Period"). The Notes are scheduled to mature on August 1, 2028. Subject to limited exceptions, the Company cannot redeem the Notes for the first five years of the term. The Company will pay interest in arrears semi-annually during the Fixed Interest Rate Period and quarterly during the Floating Interest Rate Period during the term of the Notes. The Notes constitute an unsecured and subordinated obligation of the Company and rank junior in right of payment to any senior indebtedness and obligations to general and secured creditors. The Notes qualify as Tier 2 capital for the Company for regulatory purposes, when applicable, and the portion that the Company contributes to the Bank will qualify as Tier 1 capital for the Bank. The additional capital will be used for general corporate purposes including organic growth initiatives. Subordinated debt includes associated deferred costs of $ 523,000 and $ 911,000 at March 31, 2021 and December 31, 2020, respectively. The Company also has $ 4,124,000 of mandatory redeemable trust preferred securities. The interest rate on these floating rate junior subordinated debentures adjusts quarterly, equal to the three-month LIBOR and 2.65 %. As it is anticipated that LIBOR will be discontinued after 2021, the Company is reviewing the agreements for the above debentures to determine alternative reference rates and does not anticipate there will be a significant financial statement impact.

Lease Obligations

Lease Obligations	3 Months Ended
	Mar. 31, 2021
Lease Obligations [Abstract]
Lease Obligations	Note 13 – Lease Obligations The Company leases 28 of its offices under various operating lease agreements. The leases have remaining terms of one year to 12 years . The leases contain provisions for the payment by the Company of its pro-rata share of real estate taxes, insurance, common area maintenance and other variable expenses. The Company will allocate payments made under such leases between lease and non-lease components. Some leases contain renewal options and options to purchase the assets. The Company has elected not to recognize a lease liability and a right of use asset for leases with a lease term of 12 or fewer months. The following tables present certain information related to the Company’s leases (in thousands): Three Months Ended March 31, 2021 Three Months Ended March 31, 2020 Operating lease cost $ 952 $ 854 Variable lease cost-operating leases $ 246 $ 202 At March 31, 2021 At December 31, 2020 Supplemental balance sheet information related to leases: Operating Leases Operating lease right-of-use assets $ 14,328 $ 14,988 Current liabilities $ 3,020 $ 2,992 Operating lease liabilities (noncurrent portion) 11,569 12,232 Total operating lease liabilities $ 14,589 $ 15,224 The weighted average remaining lease term for operating leases at March 31, 2021 and December 31, 2020 was 6.40 years and 6.57 years, respectively. The weighted average discount rate for operating leases at March 31, 2021 and December 31, 2020 was 2.65 percent and 2.67 percent, respectively. The following table summarizes the Company’s maturity of lease obligations for operating leases at March 31, 2021 and December 31, 2020 (in thousands): Maturities of lease liabilities: At March 31, 2021 At December 31, 2020 Operating Leases Operating Leases One year or less $ 3,358 $ 3,348 Over one year through three years 5,225 5,424 Over three years through five years 3,269 3,459 Over five years 4,065 4,415 Gross Operating Lease Liabilities $ 15,917 $ 16,646 Deferred Expenses ( 1,328 ) ( 1,422 ) Total Operating Lease Liabilities $ 14,589 $ 15,224

Subsequent Events

Subsequent Events	3 Months Ended
	Mar. 31, 2021
Subsequent Events [Abstract]
Subsequent Events	Note 14 – Subsequent Events On April 14, 2021 , the Board of Directors of the Company declared a cash dividend of $ 0.14 per share to shareholders of record of its common stock on May 10, 2021 with a payment date of May 24, 2021 .

Equity Incentive Plans (Tables)

Equity Incentive Plans (Tables)	3 Months Ended
	Mar. 31, 2021
Equity Incentive Plans [Abstract]
Summary of Status of Restricted Shares	Number of Shares Awarded Weighted Average Grant Date Fair Value Non-vested at January 1, 2021 22,304 $ 12.46 Granted 26,700 12.89 Vested - - Forfeited - - Non-vested at March 31, 2021 49,004 $ 12.70 Number of Shares Awarded Weighted Average Grant Date Fair Value Non-vested at January 1, 2020 81,278 $ 11.96 Granted - - Vested - - Forfeited - - Non-vested at March 31, 2020 81,278 $ 11.96
Summary of Stock Option Activity	The following tables present a summary of the status of the Company’s outstanding stock option awards as of March 31, 2021 and 2020. Number of Option Shares Range of Exercise Prices Weighted Average Exercise Price Outstanding at January 1, 2021 1,192,348 $ 8.93 - 13.32 $ 11.45 Options granted 66,000 12.93 12.93 Options exercised ( 7,000 ) 9.39 9.39 Options forfeited - - - Options expired - - - Outstanding at March 31, 2021 1,251,348 $ 8.93 - 13.32 $ 11.54 As of March 31, 2021, stock options which were granted and were exercisable totaled 824,536 stock options. It is Company policy to issue new shares upon share option exercise. Expected future compensation expense relating to the 426,812 shares of unvested options outstanding as of March 31, 2021 was $ 713,000 over a weighted average period of 4.99 years. Number of Option Shares Range of Exercise Prices Weighted Average Exercise Price Outstanding at January 1, 2020 1,200,975 $ 8.93 - 13.32 $ 11.45 Options granted - - - Options exercised ( 500 ) 10.55 10.55 Options forfeited - - - Options expired - - - Outstanding at March 31, 2020 1,200,475 $ 8.93 - 13.32 $ 11.45 As of March 31, 2020, stock options which were granted and were exercisable totaled 515,800 stock options.

Net Income per Common Share (Ta

Net Income per Common Share (Tables)	3 Months Ended
	Mar. 31, 2021
Net Income per Common Share [Abstract]
Schedule of Earnings Per Share, Basic and Diluted	For the Three Months Ended March 31, 2021 2020 Income Shares Per Share Income Shares Per Share (Numerator) (Denominator) Amount (Numerator) (Denominator) Amount (In Thousands, except per share data) Net income available to common stockholders $ 6,834 $ 2,179 Basic earnings per share: Income available to common stockholders $ 6,834 17,115 $ 0.40 $ 2,179 17,502 $ 0.12 Effect of dilutive securities: Stock options - 117 - 49 Diluted earnings per share: Income available to common stockholders $ 6,834 17,232 $ 0.40 $ 2,179 17,551 $ 0.12

Securities (Tables)

Securities (Tables)	3 Months Ended
	Mar. 31, 2021
Securities [Abstract]
Summary of Disaggregated Net Losses on Equity Securities	For the three months ended March 31, (In Thousands) 2021 2020 Net losses recognized during the period on equity securities $ ( 196 ) $ ( 440 ) Less: Net gains recognized during the period on equity securities sold during the period - - Unrealized losses recognized during the reporting period on equity securities still held at the reporting date $ ( 196 ) $ ( 440 )
Amortized Cost and Gross Unrealized Gains and Losses on Securities Available for Sale	March 31, 2021 Gross Gross Amortized Unrealized Unrealized Cost Gains Losses Fair Value (In Thousands) Residential Mortgage-backed securities: More than one to five years $ 3,157 $ 2 $ 72 $ 3,087 More than five to ten years 4,429 139 22 4,546 More than ten years 34,995 622 398 35,219 42,581 763 492 42,852 Corporate Debt securities: More than five to ten years 32,280 2,077 25 34,332 Municipal obligations: Less than one year 12,048 - - 12,048 More than ten years 4,183 167 - 4,350 16,231 167 - 16,398 Total securities $ 91,092 $ 3,007 $ 517 $ 93,582 December 31, 2020 Gross Gross Amortized Unrealized Unrealized Cost Gains Losses Fair Value (In Thousands) Residential Mortgage-backed securities: More than one to five years $ 3,208 $ 10 $ 67 $ 3,151 More than five to ten years 4,799 163 - 4,962 More than ten years 40,531 741 60 41,212 Sub-total: 48,538 914 127 49,325 Corporate Debt securities: More than five to ten years 32,279 1,719 13 33,985 Sub-total: 32,279 1,719 13 33,985 Municipal obligations: Due within one year 12,048 - - 12,048 Due after ten years 4,209 189 - 4,398 Sub-total: 16,257 189 - 16,446 Total Debt Securities Available $ 97,074 $ 2,822 $ 140 $ 99,756
Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value	12 Months or Less More than 12 Months Total Fair Unrealized Fair Unrealized Fair Unrealized Value Losses Value Losses Value Losses (In Thousands) March 31, 2021 Residential mortgage-backed securities $ 12,221 $ 420 $ 1,263 $ 72 $ 13,484 $ 492 Corporate Debt securities 975 25 - - 975 25 $ 13,196 $ 445 $ 1,263 $ 72 $ 14,459 $ 517 December 31, 2020 Residential mortgage-backed securities $ 6,126 $ 60 $ 1,278 $ 67 $ 7,404 $ 127 Corporate Debt Securities 5,487 13 - - 5,487 13 $ 11,613 $ 73 $ 1,278 $ 67 $ 12,891 $ 140

Loans Receivable and Allowanc_2

Loans Receivable and Allowance for Loan Losses (Tables)	3 Months Ended
	Mar. 31, 2021
Loans Receivable and Allowance for Loan Losses [Abstract]
Recorded Investment in Loans Receivable	March 31, 2021 December 31, 2020 (In Thousands) Residential one-to-four family $ 234,375 $ 244,369 Commercial and multi-family 1,700,113 1,690,836 Construction 167,224 155,967 Commercial business (1) 177,340 184,357 Home equity (2) 53,360 53,667 Consumer 851 822 2,333,263 2,330,018 Less: Deferred loan fees, net ( 1,352 ) ( 1,358 ) Allowance for loan losses ( 35,477 ) ( 33,639 ) Sub-total ( 36,829 ) ( 34,997 ) Total Loans, net $ 2,296,434 $ 2,295,021 (1) Includes business lines of credit. (2) Includes home equity lines of credit. -
Allowance for Loan Losses	The following table sets forth the activity in the Company’s allowance for loan losses for the three months ended March 31, 2021, and the related portion of the allowances for loan losses that is allocated to each loan class, as of March 31, 2021 (in thousands): Residential Commercial & Multi-family Construction Commercial Business (1) Home Equity (2) Consumer Unallocated Total Allowance for loan losses: Beginning Balance, January 1, 2021 $ 3,293 $ 21,772 $ 1,977 $ 6,306 $ 286 $ - $ 5 $ 33,639 Charge-offs: ( 57 ) - - - - - - ( 57 ) Recovery: 27 - - - 3 - - 30 Provisions: ( 426 ) 1,347 25 275 4 - 640 1,865 Ending Balance, March 31, 2021: 2,837 23,119 2,002 6,581 293 - 645 35,477 Ending Balance attributable to loans: Individually evaluated for impairment 302 381 - 4,601 23 - - 5,307 Collectively evaluated for impairment 2,535 22,738 2,002 1,980 270 - 645 30,170 Ending Balance, March 31, 2021 2,837 23,119 2,002 6,581 293 - 645 35,477 Loans Receivables: Individually evaluated for impairment 5,509 44,086 2,787 13,269 1,693 - - 67,344 Collectively evaluated for impairment 228,866 1,656,027 164,437 164,071 51,667 851 - 2,265,919 Total Gross Loans: $ 234,375 $ 1,700,113 $ 167,224 $ 177,340 $ 53,360 $ 851 $ - $ 2,333,263 (1) Includes business lines of credit. (2) Includes home equity lines of credit. The following table sets forth the activity in the Company’s allowance for loan losses for the three months ended March 31, 2020 (in thousands): Residential Commercial & Multi-family Construction Commercial Business (1) Home Equity (2) Consumer Unallocated Total Allowance for loan losses: Beginning Balance, January 1, 2020 $ 2,722 $ 15,372 $ 1,244 $ 3,790 $ 333 - $ - $ 273 $ 23,734 Charge-offs: ( 4 ) - - - - - - ( 4 ) Recovery: - - - 302 2 - - 304 Provisions: 413 ( 423 ) ( 139 ) ( 135 ) 290 5 1,489 1,500 Ending Balance March 31, 2020 3,131 14,949 1,105 3,957 625 5 1,762 25,534 Ending Balance attributable to loans: Individually evaluated for impairment 354 332 - 2,524 22 - - 3,232 Collectively evaluated for impairment 2,777 14,617 1,105 1,433 603 5 1,762 22,302 Ending Balance March 31, 2020 3,131 14,949 1,105 3,957 625 5 1,762 25,534 Loans Receivables: Individually evaluated for impairment 8,335 9,895 - 3,466 1,326 - - 23,022 Collectively evaluated for impairment 259,802 1,567,921 101,692 173,680 63,531 1,029 - 2,167,655 Total Gross Loans: $ 268,137 $ 1,577,816 $ 101,692 $ 177,146 $ 64,857 $ 1,029 $ - $ 2,190,677 _____________________________ (1) Includes business lines of credit. (2) Includes home equity lines of credit. Note 7 - Loans Receivable and Allowance for Loan Losses (Continued) The following table sets forth the amount recorded in loans receivable at December 31, 2020. The table also details the amount of total loans receivable that are evaluated individually, and collectively, for impairment and the related portion of the allowance for loan losses that is allocated to each loan class (in thousands): Residential Commercial & Multi-family Construction Commercial Business (1) Home Equity (2) Consumer Unallocated Total Allowance for credit losses: Ending Balance attributable to loans: Individually evaluated for impairment $ 416 $ 378 $ - $ 3,640 $ 27 $ - $ - $ 4,461 Collectively evaluated for impairment 2,877 21,394 1,977 2,666 259 - 5 29,178 Ending Balance, December 31, 2020 $ 3,293 $ 21,772 $ 1,977 $ 6,306 $ 286 $ - $ 5 $ 33,639 Loans Receivables: - Individually evaluated for impairment $ 7,281 $ 61,854 $ - $ 12,492 $ 1,574 $ - $ - $ 83,201 Collectively evaluated for impairment 237,088 1,628,982 155,967 171,865 52,093 822 - 2,246,817 Total Gross Loans: $ 244,369 $ 1,690,836 $ 155,967 $ 184,357 $ 53,667 $ 822 $ - $ 2,330,018 (1) Includes business lines of credit. (2) Includes home equity lines of credit.
Impaired Loans	The following table summarizes the average recorded investment and interest income recognized on impaired loans with no related allowance recorded by portfolio class for the three months ended March 31, 2021 and 2020 (in thousands): Three Months Ended March 31, 2021 2021 2020 2020 Average Interest Average Interest Recorded Income Recorded Income Investment Recognized Investment Recognized Loans with no related allowance recorded: Residential one-to-four family $ 3,453 $ 34 $ 4,656 $ 52 Commercial and Multi-family 44,958 282 10,322 99 Construction 1,394 36 - - Commercial business (1) 5,171 13 2,013 43 Home equity (2) 1,196 10 848 9 Total Impaired Loans with no allowance recorded: $ 56,172 $ 375 $ 17,839 $ 203 Loans with an allowance recorded: Residential one-to-four family $ 2,943 $ 32 $ 3,741 $ 41 Commercial and Multi-family 8,013 129 1,241 20 Commercial business (1) 7,710 93 1,690 3 Home equity (2) 438 2 460 4 Consumer - - - - Total Impaired Loans with an allowance recorded: $ 19,104 $ 256 $ 7,132 $ 68 Total Impaired Loans: $ 75,276 $ 631 $ 24,971 $ 271 __________ (1) Includes business lines of credit. (2) Includes home equity lines of credit. (3) Does not include accretable yield on loans acquired with deteriorated credit. The following table summarizes the recorded investment by portfolio class at March 31, 2021 and December 31, 2020. (in thousands): As of March 31, 2021 As of December 31, 2020 Recorded Unpaid Principal Related Recorded Unpaid Principal Related Investment Balance Allowance Investment Balance Allowance Loans with no related allowance recorded: Residential one-to-four family $ 2,821 $ 3,210 $ - $ 4,084 $ 4,660 $ - Commercial and multi-family 32,357 33,761 - 57,558 58,739 - Construction 2,787 2,787 - - - - Commercial business (1) 4,498 12,573 - 5,844 17,687 - Home equity (2) 1,268 1,270 - 1,124 1,126 - Total Impaired Loans with no related allowance recorded: $ 43,731 $ 53,601 $ - $ 68,610 $ 82,212 $ - Loans with an allowance recorded: Residential one-to-four family $ 2,688 $ 2,723 $ 302 $ 3,197 $ 3,252 $ 416 Commercial and Multi-family 11,729 15,584 381 4,296 4,501 378 Commercial business (1) 8,771 20,662 4,601 6,648 12,511 3,640 Home equity (2) 425 425 23 450 458 27 Total Impaired Loans with an allowance recorded: $ 23,613 $ 39,394 $ 5,307 $ 14,591 $ 20,722 $ 4,461 Total Impaired Loans: $ 67,344 $ 92,995 $ 5,307 $ 83,201 $ 102,934 $ 4,461 __________ (1) Includes business lines of credit. (2) Includes home equity lines of credit.
Troubled Debt Restructurings	At March 31,2021 At December 31, 2020 (In thousands) Recorded investment in TDRs: Accrual status $ 13,474 $ 13,760 Non-accrual status 1,074 2,303 Total recorded investment in TDRs $ 14,548 $ 16,063
Delinquency Status of Total Loans	The following table sets forth the delinquency status of total loans receivable as of March 31, 2021: Loans Receivable 30-59 Days 60-90 Days Greater Than Total Past Total Loans >90 Days Past Due Past Due 90 Days Due Current Receivable and Accruing (In Thousands) Residential one-to-four family $ 936 $ - $ 227 $ 1,163 $ 233,212 $ 234,375 $ - Commercial and multi-family 13,148 4,410 2,447 20,005 1,680,108 1,700,113 - Construction 2,787 - - 2,787 164,437 167,224 - Commercial business (1) 457 1,153 4,796 6,406 170,934 177,340 - Home equity (2) 235 39 427 701 52,659 53,360 - Consumer - - - - 851 851 - Total $ 17,563 $ 5,602 $ 7,897 $ 31,062 $ 2,302,201 $ 2,333,263 $ - _________ (1) Includes business lines of credit. (2) Includes home equity lines of credit. The following table sets forth the delinquency status of total loans receivable at December 31, 2020: Loans Receivable 30-59 Days 60-90 Days Greater Than Total Past Total Loans >90 Days Past Due Past Due 90 Days Due Current Receivable and Accruing (In Thousands) Originated loans: Residential one-to-four family $ 507 $ 266 $ 664 $ 1,437 $ 242,932 $ 244,369 $ 125 Commercial and multi-family 15,910 2,996 1,334 20,240 1,670,596 1,690,836 - Construction - - - - 155,967 155,967 - Commercial business (1) 3,889 904 3,354 8,147 176,210 184,357 133 Home equity (2) 541 12 502 1,055 52,612 53,667 75 Consumer - - - - 822 822 - Total $ 20,847 $ 4,178 $ 5,854 $ 30,879 $ 2,299,139 $ 2,330,018 $ 333 (1) Includes business lines of credit. (2) Includes home equity lines of credit. Note 7 - Loans Receivable and Allowance for Loan Losses (Continued) The table below sets forth the amounts and types of non-accrual loans in the Bank’s loan portfolio at March 31, 2021 and December 31, 2020, respectively. Loans are placed on non-accrual status when they become more than 90 days delinquent, or when the collection of principal and/or interest become doubtful. As of March 31, 2021, and December 31, 2020, non-accrual loans differed from the amount of total loans past due greater than 90 days due to loans which are maintained on non-accrual status for a minimum of six months until the borrower has demonstrated its ability to satisfy the terms of the restructured loan. There were $ 7.3 million at March 31, 2021 and $ 11.9 million at December 31, 2020 in nonaccrual loans that were less than ninety days past due. Nonaccrual loans do not include loans acquired with deteriorated credit quality which were recorded at their fair value at acquisition and totaled $ 884,000 at March 31, 2021 and $ 1.1 million at December 31, 2020. As of March 31, 2021 As of December 31, 2020 (In Thousands) (In Thousands) Non-Accruing Loans: Originated loans: Residential one-to-four family $ 701 $ 1,736 Commercial and multi-family 7,962 8,721 Commercial business (1) 5,307 5,383 Home equity (2) 435 556 Total $ 14,405 $ 16,396 _________ (1) Includes business lines of credit. (2) Includes home equity lines of credit. Had non-accrual loans been performing in accordance with their original terms, the interest income recognized for the three months ended March 31, 2021 and December 31, 2020 would have been approximately $ 343,000 and $ 1.5 million, respectively. The Bank has not committed to lend additional funds to the borrowers whose loans have been placed on nonaccrual status. At March 31, 2021 and December 31, 2020, there were $ 0 and $ 333,000 , respectively, of loans which were more than ninety days past due and still accruing interest.
Loan Portfolio by Pass Rating	Pass Special Mention Substandard Total Residential one-to-four family $ 232,669 $ 724 $ 982 $ 234,375 Commercial and multi-family 1,622,917 38,464 38,732 1,700,113 Construction 164,437 - 2,787 167,224 Commercial business (1) 162,408 1,998 12,934 177,340 Home equity (2) 52,617 - 743 53,360 Consumer 851 - - 851 Total Gross Loans $ 2,235,899 $ 41,186 $ 56,178 $ 2,333,263 _________ (1) Includes business lines of credit and PPP loans. (2) Includes home equity lines of credit. Note 7 - Loans Receivable and Allowance for Loan Losses The following table presents the loan portfolio types summarized by the aggregate pass rating and the classified ratings of special mention and substandard within the Company’s internal risk rating system as of December 31, 2020 (In thousands). As of December 31, 2020, the Company had no loans with the classified rating of doubtful or loss. Pass Special Mention Substandard Total Residential one-to-four family $ 241,237 $ 1,087 $ 2,045 $ 244,369 Commercial and multi-family 1,631,838 2,152 56,846 1,690,836 Construction 155,967 - - 155,967 Commercial business (1) 173,833 1,497 9,027 184,357 Home equity (2) 53,005 - 662 53,667 Consumer 822 - - 822 Total Gross Loans $ 2,256,702 $ 4,736 $ 68,580 $ 2,330,018 ________ (1) Includes business lines of credit. (2) Includes home equity lines of credit.

Fair Values of Financial Inst_2

Fair Values of Financial Instruments (Tables)	3 Months Ended
	Mar. 31, 2021
Fair Values of Financial Instruments [Abstract]
Fair Value Measurements, Recurring	(Level 1) (Level 2) Quoted Prices in Significant (Level 3) Active Markets Other Significant for Identical Observable Unobservable Description Total Assets Inputs Inputs As of March 31, 2021: Securities Debt Securities Available for Sale $ 93,582 $ - $ 93,582 $ - Marketable Equities $ 18,278 $ 18,278 $ - $ - Total Securities $ 111,860 $ 18,278 $ 93,582 $ - As of December 31, 2020: Securities Debt Securities Available for Sale $ 99,756 $ - $ 99,756 $ - Marketable Equities $ 17,717 $ 17,717 $ - $ - Total Securities $ 117,473 $ 17,717 $ 99,756 $ -
Fair Value Measurements, Nonrecurring	(Level 1) (Level 2) Quoted Prices in Significant (Level 3) Active Markets Other Significant for Identical Observable Unobservable Description Total Assets Inputs Inputs As of March 31, 2021 Impaired Loans $ 18,306 $ - $ - $ 18,306 Other real estate owned $ 414 $ - $ - $ 414 As of December 31, 2020: Impaired Loans $ 10,130 $ - $ - $ 10,130 Other real estate owned $ 414 $ - $ - $ 414
Quantitative Information about Level 3 Fair Value Measurements	Quantitative Information about Level 3 Fair Value Measurements Fair Value Valuation Unobservable Estimate Techniques Input Range March 31, 2021: Impaired Loans $ 18,306 Appraisal of collateral (1) Appraisal adjustments (2) 0 %- 10 % Other real estate owned $ 414 Appraisal of collateral (1) Appraisal adjustments (2) 0 %- 10 % Fair Value Valuation Unobservable Estimate Techniques Input Range December 31, 2020: Impaired Loans $ 10,130 Appraisal of collateral (1) Appraisal adjustments (2) 0 %- 10 % Other real estate owned $ 414 Appraisal of collateral (1) Appraisal adjustments (2) 0 %- 10 % (1) Fair value is generally determined through independent appraisals of the underlying collateral, which generally include various level 3 inputs which are not objectively determinable. (2) Appraisals may be adjusted by management for qualitative factors such as economic conditions and estimated liquidation expenses. The range of liquidation expenses and other appraisal adjustments are presented as a percent of the appraisal.
Carrying Values and Estimated Fair Values of Financial Instruments	As of March 31, 2021 Quoted Prices in Active Significant Significant Carrying Markets for Identical Assets Other Observable Inputs Unobservable Inputs Value Fair Value (Level 1) (Level 2) (Level 3) (In Thousands) Financial assets: Cash and cash equivalents $ 296,938 $ 296,938 $ 296,938 $ - $ - Interest-earning time deposits 735 735 - 735 - Debt securities available for sale 93,582 93,582 - 93,582 - Equity investments 18,278 18,278 18,278 - - Loans held for sale 1,147 1,147 - 1,147 - Loans receivable, net 2,296,434 2,294,631 - - 2,294,631 FHLB of New York stock, at cost 8,920 8,920 - 8,920 - Accrued interest receivable 12,056 12,056 - 12,056 - Other Real Estate Owned 414 414 - - 414 Financial liabilities: Deposits 2,404,135 2,408,469 1,719,149 689,320 - Borrowings 133,298 131,806 - 131,806 - Subordinated debentures 37,101 36,686 - 36,686 - Accrued interest payable 807 807 - 807 - As of December 31, 2020 Quoted Prices in Active Significant Significant Carrying Markets for Identical Assets Other Observable Inputs Unobservable Inputs Value Fair Value (Level 1) (Level 2) (Level 3) (In Thousands) Financial assets: Cash and cash equivalents $ 261,229 $ 261,229 $ 261,229 $ - $ - Interest-earning time deposits 735 735 - 735 - Debt securities available for sale 99,756 99,756 - 99,756 - Equity investments 17,717 17,717 17,717 - - Loans held for sale 3,530 3,530 - 3,530 - Loans receivable, net 2,295,021 2,309,118 - - 2,309,118 FHLB of New York stock, at cost 11,324 11,324 - 11,324 - Accrued interest receivable 12,924 12,924 - 12,924 - Other Real Estate Owned - - - - - Financial liabilities: Deposits 2,318,050 2,323,561 1,627,871 695,690 - Borrowings 191,161 194,899 - 194,899 - Subordinated debentures 37,042 37,252 - 37,252 - Accrued interest payable 1,463 1,463 - 1,463 -

Lease Obligations (Tables)

Lease Obligations (Tables)	3 Months Ended
	Mar. 31, 2021
Lease Obligations [Abstract]
Schedule of Lease Information	Three Months Ended March 31, 2021 Three Months Ended March 31, 2020 Operating lease cost $ 952 $ 854 Variable lease cost-operating leases $ 246 $ 202 At March 31, 2021 At December 31, 2020 Supplemental balance sheet information related to leases: Operating Leases Operating lease right-of-use assets $ 14,328 $ 14,988 Current liabilities $ 3,020 $ 2,992 Operating lease liabilities (noncurrent portion) 11,569 12,232 Total operating lease liabilities $ 14,589 $ 15,224
Summary of Maturity of Lease Obligations for Operating Leases	Maturities of lease liabilities: At March 31, 2021 At December 31, 2020 Operating Leases Operating Leases One year or less $ 3,358 $ 3,348 Over one year through three years 5,225 5,424 Over three years through five years 3,269 3,459 Over five years 4,065 4,415 Gross Operating Lease Liabilities $ 15,917 $ 16,646 Deferred Expenses ( 1,328 ) ( 1,422 ) Total Operating Lease Liabilities $ 14,589 $ 15,224

Equity Incentive Plans (Narrati

Equity Incentive Plans (Narrative) (Details) - USD ($)	Feb. 19, 2021	Feb. 10, 2021	Mar. 31, 2021	Mar. 31, 2020
Defined Benefit Plan Disclosure [Line Items]
Options granted			66,000
Shares underlying unexercised options			426,812
Expected future compensation expense, unexercised options			$ 713,000
Options [Member]
Defined Benefit Plan Disclosure [Line Items]
Expected future compensation expense, weighted average period for recognition			4 years 11 months 26 days
Restricted Stock [Member]
Defined Benefit Plan Disclosure [Line Items]
Expected future expenses relating to non-vested restricted shares			$ 361,000
Expected future compensation expense, weighted average period for recognition			3 years 3 months 10 days
2018 Equity Incentive Plan [Member]
Defined Benefit Plan Disclosure [Line Items]
Shares authorized for issuance			1,000,000
2011 Stock Plan [Member]
Defined Benefit Plan Disclosure [Line Items]
Shares authorized for issuance			900,000
Directors [Member] | 2018 Equity Incentive Plan [Member] | Options [Member]
Defined Benefit Plan Disclosure [Line Items]
Options granted		66,000
Vesting period		5 years
Directors [Member] | 2018 Equity Incentive Plan [Member] | Restricted Stock [Member]
Defined Benefit Plan Disclosure [Line Items]
Restricted stock issued	300	26,400
Vesting period	2 years	4 years

Equity Incentive Plans (Summary

Equity Incentive Plans (Summary of Status of Restricted Shares) (Details) - $ / shares	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Equity Incentive Plans [Abstract]
Number of Shares Awarded, Non-vested at beginning of period	22,304	81,278
Number of Shares Awarded, Granted	26,700
Number of Shares Awarded, Vested
Number of Shares Awarded, Forfeited
Number of Shares Awarded, Non-vested at end of period	49,004	81,278
Weighted Average Grant Date Fair Value, Non-vested at beginning of period	$ 12.46	$ 11.96
Weighted Average Grant Date Fair Value, Granted	12.89
Weighted Average Grant Date Fair Value, Vested
Weighted Average Grant Date Fair Value, Forfeited
Weighted Average Grant Date Fair Value, Non-vested at end of period	$ 12.70	$ 11.96

Equity Incentive Plans (Summa_2

Equity Incentive Plans (Summary of Stock Option Activity) (Details) - $ / shares	3 Months Ended		12 Months Ended
	Mar. 31, 2021	Mar. 31, 2020	Dec. 31, 2020	Dec. 31, 2019
Equity Incentive Plans [Abstract]
Outstanding, Beginning Balance - Number of Options	1,192,348	1,200,975	1,200,975
Options Granted - Number of Options	66,000
Options Exercised - Number of Options	(7,000)	(500)
Options Forfeited - Number of Options
Options Expired - Number of Options
Outstanding, Ending Balance - Number of Options	1,251,348	1,200,475	1,192,348	1,200,975
Outstanding, Range of Exercise Price, Lower Range Limit (per share)	$ 8.93	$ 8.93	$ 8.93	$ 8.93
Outstanding, Range of Exercise Price, Upper Range Limit (per share)	13.32	13.32	13.32	13.32
Options Granted, Exercise Price	12.93
Options Exercised - Exercise Price	9.39	10.55
Outstanding Number of Options, Beginning Balance - Weighted Average Exercise Price	11.45	11.45	11.45
Number of Options Granted - Weighted Average Exercise Price	12.93
Number of Options, Exercised - Weighted Average Exercise Price	9.39	10.55
Outstanding Number of Options, Ending Balance - Weighted Average Exercise Price	$ 11.54	$ 11.45	$ 11.45	$ 11.45
Exercisable - Number of Options	824,536	515,800

Net Income per Common Share (Na

Net Income per Common Share (Narrative) (Details) - shares	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Net Income per Common Share [Abstract]
Anti-dilutive outstanding options	0	687

Net Income Per Common Share (Sc

Net Income Per Common Share (Schedule of Earnings Per Share, Basic and Diluted) (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Net Income per Common Share [Abstract]
Net income available to common stockholders	$ 7,117	$ 2,521
Basic earnings per share- Income available to Common stockholders	6,834	2,179
Diluted earnings per share- Income available to Common stockholders	$ 6,834	$ 2,179
Basic earnings per share- Income available to Common stockholders, Shares	17,115	17,502
Effect of dilutive securities: Stock options: Shares	117	49
Diluted earnings per share- Income available to Common stockholders, Shares	17,232	17,551
Basic earnings per share- Income available to Common stockholders, Per share amount	$ 0.40	$ 0.12
Diluted earnings per share - Income available to Common stockholders, Per share amount	$ 0.40	$ 0.12

Securities (Summary of Disaggre

Securities (Summary of Disaggregated Net Losses on Equity Securities) (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Securities [Abstract]
Net losses recognized during the period on equity securities	$ (196)	$ (440)
Unrealized losses recognized during the reporting period on equity securities still held at the reporting date	$ (196)	$ (440)

Securities (Amortized Cost and

Securities (Amortized Cost and Gross Unrealized Gains and Losses on Securities Available for Sale) (Details) - USD ($) $ in Thousands	Mar. 31, 2021	Dec. 31, 2020
Schedule of Available-for-sale Securities [Line Items]
Debt Securities, Amortized Cost	$ 91,092	$ 97,074
Debt securities: Gross Unrealized Gains	3,007	2,822
Debt securities: Gross Unrealized Losses	517	140
Debt securities: Fair Value	93,582	99,756
Residential Mortgage-backed securities [Member]
Schedule of Available-for-sale Securities [Line Items]
Debt securities, More than one to five years, Amortized Cost	3,157	3,208
Debt securities, More than five to ten years, Amortized Cost	4,429	4,799
Debt securities, More than ten years, Amortized Cost	34,995	40,531
Debt Securities, Amortized Cost	42,581	48,538
Debt securities, More than one to five years, Gross Unrealized Gains	2	10
Debt securities: More than five to ten years, Gross Unrealized Gains	139	163
Debt securities, More than ten years, Gross Unrealized Gains	622	741
Debt securities: Gross Unrealized Gains	763	914
Debt securities: More than one to five years, Gross Unrealized Losses	72	67
Debt securities: More than five to ten years, Gross Unrealized Losses	22
Debt securities: More than ten years, Gross Unrealized Losses	398	60
Debt securities: Gross Unrealized Losses	492	127
Debt securities: More than one to five years, Fair Value	3,087	3,151
Debt securities: More than five to ten years, Fair Value	4,546	4,962
Debt securities: More than ten years, Fair Value	35,219	41,212
Debt securities: Fair Value	42,852	49,325
Corporate Debt Securities [Member]
Schedule of Available-for-sale Securities [Line Items]
Debt securities, More than five to ten years, Amortized Cost	32,280	32,279
Debt Securities, Amortized Cost		32,279
Debt securities: More than five to ten years, Gross Unrealized Gains	2,077	1,719
Debt securities: Gross Unrealized Gains		1,719
Debt securities: More than five to ten years, Gross Unrealized Losses	25	13
Debt securities: Gross Unrealized Losses		13
Debt securities: More than five to ten years, Fair Value	34,332	33,985
Debt securities: Fair Value		33,985
Municipal Obligations [Member]
Schedule of Available-for-sale Securities [Line Items]
Debt securities, Within one year, Amortized Cost	12,048	12,048
Debt securities, More than ten years, Amortized Cost	4,183	4,209
Debt Securities, Amortized Cost	16,231	16,257
Debt securities, More than ten years, Gross Unrealized Gains	167	189
Debt securities: Gross Unrealized Gains	167	189
Debt securities: Less than one year, Fair Value	12,048	12,048
Debt securities: More than ten years, Fair Value	4,350	4,398
Debt securities: Fair Value	$ 16,398	$ 16,446

Securities (Available-for-Sale

Securities (Available-for-Sale Securities, Continuous Unrealized Loss Position, Fair Value ) (Details) - USD ($) $ in Thousands	Mar. 31, 2021	Dec. 31, 2020
Schedule of Available-for-sale Securities [Line Items]
Debt Securities, 12 Months or Less - Fair Value	$ 13,196	$ 11,613
Debt Securities, More than 12 Months - Fair Value	1,263	1,278
Debt Securities - Total Fair Value	14,459	12,891
Debt Securities, 12 Months or Less - Unrealized Losses	445	73
Debt Securities, More than 12 Months - Unrealized Losses	72	67
Debt Securities - Total Unrealized Losses	517	140
Residential Mortgage-backed securities [Member]
Schedule of Available-for-sale Securities [Line Items]
Debt Securities, 12 Months or Less - Fair Value	12,221	6,126
Debt Securities, More than 12 Months - Fair Value	1,263	1,278
Debt Securities - Total Fair Value	13,484	7,404
Debt Securities, 12 Months or Less - Unrealized Losses	420	60
Debt Securities, More than 12 Months - Unrealized Losses	72	67
Debt Securities - Total Unrealized Losses	492	127
Corporate Debt Securities [Member]
Schedule of Available-for-sale Securities [Line Items]
Debt Securities, 12 Months or Less - Fair Value	975	5,487
Debt Securities - Total Fair Value	975	5,487
Debt Securities, 12 Months or Less - Unrealized Losses	25	13
Debt Securities - Total Unrealized Losses	$ 25	$ 13

Loans Receivable and Allowanc_3

Loans Receivable and Allowance for Loan Losses (Narrative) (Details)	3 Months Ended		12 Months Ended
	Mar. 31, 2021USD ($)loan	Mar. 31, 2020USD ($)	Dec. 31, 2020USD ($)
Accounts, Notes, Loans and Financing Receivable [Line Items]
Non-accrual loans, interest income lost	$ 343,000		$ 1,500,000
Loans Receivable >90 Days and Accruing	0		333,000
Loans acquired with deteriorated credit quality, fair value	884,000		1,100,000
Troubled debt restructurings, subsequent default, amount	$ 127,449	$ 0
Troubled debt restructuring, subsequent default, number | loan	1
Past due loans	$ 31,062,000		30,879,000
Less Than 90 Days Past Due [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Past due loans	$ 7,300,000		$ 11,900,000

Loans Receivable and Allowanc_4

Loans Receivable and Allowance for Loan Losses (Recorded Investment in Loans Receivable) (Details) - USD ($) $ in Thousands	Mar. 31, 2021	Dec. 31, 2020	Mar. 31, 2020
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans receivable, gross	$ 2,333,263	$ 2,330,018	$ 2,190,677
Deferred loan fees, net	(1,352)	(1,358)
Allowance for loan losses	(35,477)	(33,639)
Sub-total	(36,829)	(34,997)
Net Loans	2,296,434	2,295,021
Residential [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans receivable, gross	234,375	244,369	268,137
Commercial & Multi-family [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans receivable, gross	1,700,113	1,690,836	1,577,816
Construction [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans receivable, gross	167,224	155,967	101,692
Commercial Business [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans receivable, gross	177,340	184,357	177,146
Home Equity [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans receivable, gross	53,360	53,667	64,857
Consumer [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans receivable, gross	$ 851	$ 822	$ 1,029

Loans Receivable and Allowanc_5

Loans Receivable and Allowance for Loan Losses (Allowance for Loan Losses) (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020	Dec. 31, 2020
Accounts, Notes, Loans and Financing Receivable [Line Items]
Allowance for loan losses: Beginning Balance	$ 33,639	$ 23,734
Allowance for loan losses: Charge-offs	(57)	(4)
Allowance for loan losses: Recovery	30	304
Allowance for loan losses: Provisions	1,865	1,500
Allowance for loan losses: Ending balance: individually evaluated for impairment	5,307	3,232	$ 4,461
Allowance for loan losses: Ending balance: collectively evaluated for impairment	30,170	22,302	29,178
Allowance for loan losses: Ending Balance	35,477	25,534
Loans receivables: Ending balance: individually evaluated for impairment	67,344	23,022	83,201
Loans receivables: Ending balance: collectively evaluated for impairment	2,265,919	2,167,655	2,246,817
Loans receivables: Ending balance	2,333,263	2,190,677	2,330,018
Residential [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Allowance for loan losses: Beginning Balance	3,293	2,722
Allowance for loan losses: Charge-offs	(57)	(4)
Allowance for loan losses: Recovery	27
Allowance for loan losses: Provisions	(426)	413
Allowance for loan losses: Ending balance: individually evaluated for impairment	302	354	416
Allowance for loan losses: Ending balance: collectively evaluated for impairment	2,535	2,777	2,877
Allowance for loan losses: Ending Balance	2,837	3,131
Loans receivables: Ending balance: individually evaluated for impairment	5,509	8,335	7,281
Loans receivables: Ending balance: collectively evaluated for impairment	228,866	259,802	237,088
Loans receivables: Ending balance	234,375	268,137	244,369
Commercial & Multi-family [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Allowance for loan losses: Beginning Balance	21,772	15,372
Allowance for loan losses: Provisions	1,347	(423)
Allowance for loan losses: Ending balance: individually evaluated for impairment	381	332	378
Allowance for loan losses: Ending balance: collectively evaluated for impairment	22,738	14,617	21,394
Allowance for loan losses: Ending Balance	23,119	14,949
Loans receivables: Ending balance: individually evaluated for impairment	44,086	9,895	61,854
Loans receivables: Ending balance: collectively evaluated for impairment	1,656,027	1,567,921	1,628,982
Loans receivables: Ending balance	1,700,113	1,577,816	1,690,836
Construction [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Allowance for loan losses: Beginning Balance	1,977	1,244
Allowance for loan losses: Provisions	25	(139)
Allowance for loan losses: Ending balance: collectively evaluated for impairment	2,002	1,105	1,977
Allowance for loan losses: Ending Balance	2,002	1,105
Loans receivables: Ending balance: individually evaluated for impairment	2,787
Loans receivables: Ending balance: collectively evaluated for impairment	164,437	101,692	155,967
Loans receivables: Ending balance	167,224	101,692	155,967
Commercial Business [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Allowance for loan losses: Beginning Balance	6,306	3,790
Allowance for loan losses: Recovery		302
Allowance for loan losses: Provisions	275	(135)
Allowance for loan losses: Ending balance: individually evaluated for impairment	4,601	2,524	3,640
Allowance for loan losses: Ending balance: collectively evaluated for impairment	1,980	1,433	2,666
Allowance for loan losses: Ending Balance	6,581	3,957
Loans receivables: Ending balance: individually evaluated for impairment	13,269	3,466	12,492
Loans receivables: Ending balance: collectively evaluated for impairment	164,071	173,680	171,865
Loans receivables: Ending balance	177,340	177,146	184,357
Home Equity [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Allowance for loan losses: Beginning Balance	286	333
Allowance for loan losses: Recovery	3	2
Allowance for loan losses: Provisions	4	290
Allowance for loan losses: Ending balance: individually evaluated for impairment	23	22	27
Allowance for loan losses: Ending balance: collectively evaluated for impairment	270	603	259
Allowance for loan losses: Ending Balance	293	625
Loans receivables: Ending balance: individually evaluated for impairment	1,693	1,326	1,574
Loans receivables: Ending balance: collectively evaluated for impairment	51,667	63,531	52,093
Loans receivables: Ending balance	53,360	64,857	53,667
Consumer [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Allowance for loan losses: Provisions		5
Allowance for loan losses: Ending balance: collectively evaluated for impairment		5
Allowance for loan losses: Ending Balance		5
Loans receivables: Ending balance: collectively evaluated for impairment	851	1,029	822
Loans receivables: Ending balance	851	1,029	822
Unallocated [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Allowance for loan losses: Beginning Balance	5	273
Allowance for loan losses: Provisions	640	1,489
Allowance for loan losses: Ending balance: collectively evaluated for impairment	645	1,762	$ 5
Allowance for loan losses: Ending Balance	$ 645	$ 1,762

Loans Receivable and Allowanc_6

Loans Receivable and Allowance for Loan Losses (Impaired Loans) (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020	Dec. 31, 2020
Accounts, Notes, Loans and Financing Receivable [Line Items]
Average Recorded Investment - With no related allowance recorded	$ 56,172	$ 17,839
Average Recorded Investment - With an allowance recorded	19,104	7,132
Average Recorded Investment - Total	75,276	24,971
Interest Income Recognized - With no related allowance recorded	375	203
Interest Income Recognized - With an allowance recorded	256	68
Interest Income Recognized - Total	631	271
Recorded Investment - With no related allowance recorded	43,731		$ 68,610
Recorded Investment - With an allowance recorded	23,613		14,591
Recorded Investment - Total	67,344		83,201
Unpaid Principal Balance - With no related allowance recorded	53,601		82,212
Unpaid Principal Balance - With an allowance recorded	39,394		20,722
Unpaid Principal Balance - Total	92,995		102,934
Related Allowance	5,307		4,461
Residential [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Average Recorded Investment - With no related allowance recorded	3,453	4,656
Average Recorded Investment - With an allowance recorded	2,943	3,741
Interest Income Recognized - With no related allowance recorded	34	52
Interest Income Recognized - With an allowance recorded	32	41
Recorded Investment - With no related allowance recorded	2,821		4,084
Recorded Investment - With an allowance recorded	2,688		3,197
Unpaid Principal Balance - With no related allowance recorded	3,210		4,660
Unpaid Principal Balance - With an allowance recorded	2,723		3,252
Related Allowance	302		416
Commercial & Multi-family [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Average Recorded Investment - With no related allowance recorded	44,958	10,322
Average Recorded Investment - With an allowance recorded	8,013	1,241
Interest Income Recognized - With no related allowance recorded	282	99
Interest Income Recognized - With an allowance recorded	129	20
Recorded Investment - With no related allowance recorded	32,357		57,558
Recorded Investment - With an allowance recorded	11,729		4,296
Unpaid Principal Balance - With no related allowance recorded	33,761		58,739
Unpaid Principal Balance - With an allowance recorded	15,584		4,501
Related Allowance	381		378
Construction [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Average Recorded Investment - With no related allowance recorded	1,394
Interest Income Recognized - With no related allowance recorded	36
Recorded Investment - With no related allowance recorded	2,787
Unpaid Principal Balance - With no related allowance recorded	2,787
Commercial Business [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Average Recorded Investment - With no related allowance recorded	5,171	2,013
Average Recorded Investment - With an allowance recorded	7,710	1,690
Interest Income Recognized - With no related allowance recorded	13	43
Interest Income Recognized - With an allowance recorded	93	3
Recorded Investment - With no related allowance recorded	4,498		5,844
Recorded Investment - With an allowance recorded	8,771		6,648
Unpaid Principal Balance - With no related allowance recorded	12,573		17,687
Unpaid Principal Balance - With an allowance recorded	20,662		12,511
Related Allowance	4,601		3,640
Home Equity [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Average Recorded Investment - With no related allowance recorded	1,196	848
Average Recorded Investment - With an allowance recorded	438	460
Interest Income Recognized - With no related allowance recorded	10	9
Interest Income Recognized - With an allowance recorded	2	$ 4
Recorded Investment - With no related allowance recorded	1,268		1,124
Recorded Investment - With an allowance recorded	425		450
Unpaid Principal Balance - With no related allowance recorded	1,270		1,126
Unpaid Principal Balance - With an allowance recorded	425		458
Related Allowance	$ 23		$ 27

Loans Receivable and Allowanc_7

Loans Receivable and Allowance for Loan Losses (Delinquency Status of Total Loans) (Details) - USD ($)	Mar. 31, 2021	Dec. 31, 2020
Accounts, Notes, Loans and Financing Receivable [Line Items]
Past Due	$ 31,062,000	$ 30,879,000
Current	2,302,201,000	2,299,139,000
Financing Receivable, Net, Total	2,333,263,000	2,330,018,000
Loans Receivable >90 Days and Accruing	0	333,000
30 to 59 Days Past Due [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Past Due	17,563,000	20,847,000
60 to 90 Days Past Due [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Past Due	5,602,000	4,178,000
Greater than 90 Days Past Due [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Past Due	7,897,000	5,854,000
Originated loans [Member] | Residential [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Past Due	1,163,000	1,437,000
Current	233,212,000	242,932,000
Financing Receivable, Net, Total	234,375,000	244,369,000
Loans Receivable >90 Days and Accruing		125,000
Originated loans [Member] | Residential [Member] | 30 to 59 Days Past Due [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Past Due	936,000	507,000
Originated loans [Member] | Residential [Member] | 60 to 90 Days Past Due [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Past Due		266,000
Originated loans [Member] | Residential [Member] | Greater than 90 Days Past Due [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Past Due	227,000	664,000
Originated loans [Member] | Commercial & Multi-family [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Past Due	20,005,000	20,240,000
Current	1,680,108,000	1,670,596,000
Financing Receivable, Net, Total	1,700,113,000	1,690,836,000
Loans Receivable >90 Days and Accruing
Originated loans [Member] | Commercial & Multi-family [Member] | 30 to 59 Days Past Due [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Past Due	13,148,000	15,910,000
Originated loans [Member] | Commercial & Multi-family [Member] | 60 to 90 Days Past Due [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Past Due	4,410,000	2,996,000
Originated loans [Member] | Commercial & Multi-family [Member] | Greater than 90 Days Past Due [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Past Due	2,447,000	1,334,000
Originated loans [Member] | Construction [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Past Due	2,787,000
Current	164,437,000	155,967,000
Financing Receivable, Net, Total	167,224,000	155,967,000
Loans Receivable >90 Days and Accruing
Originated loans [Member] | Construction [Member] | 30 to 59 Days Past Due [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Past Due	2,787,000
Originated loans [Member] | Commercial Business [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Past Due	6,406,000	8,147,000
Current	170,934,000	176,210,000
Financing Receivable, Net, Total	177,340,000	184,357,000
Loans Receivable >90 Days and Accruing		133,000
Originated loans [Member] | Commercial Business [Member] | 30 to 59 Days Past Due [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Past Due	457,000	3,889,000
Originated loans [Member] | Commercial Business [Member] | 60 to 90 Days Past Due [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Past Due	1,153,000	904,000
Originated loans [Member] | Commercial Business [Member] | Greater than 90 Days Past Due [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Past Due	4,796,000	3,354,000
Originated loans [Member] | Home Equity [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Past Due	701,000	1,055,000
Current	52,659,000	52,612,000
Financing Receivable, Net, Total	53,360,000	53,667,000
Loans Receivable >90 Days and Accruing		75,000
Originated loans [Member] | Home Equity [Member] | 30 to 59 Days Past Due [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Past Due	235,000	541,000
Originated loans [Member] | Home Equity [Member] | 60 to 90 Days Past Due [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Past Due	39,000	12,000
Originated loans [Member] | Home Equity [Member] | Greater than 90 Days Past Due [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Past Due	427,000	502,000
Originated loans [Member] | Consumer [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Current	851,000	822,000
Financing Receivable, Net, Total	851,000	822,000
Loans Receivable >90 Days and Accruing

Loans Receivable and Allowanc_8

Loans Receivable and Allowance for Loan Losses (Troubled Debt Restructurings) (Details)	3 Months Ended
	Mar. 31, 2021USD ($)loan	Mar. 31, 2020USD ($)loan	Dec. 31, 2020USD ($)
Financing Receivable, Modifications [Line Items]
Total recorded investment in TDRs	$ 14,548,000		$ 16,063,000
Number of Contracts | loan	1	1
Post-Modification Outstanding Recorded Investments	$ 96,532	$ 216,102
Performing Financing Receivable [Member]
Financing Receivable, Modifications [Line Items]
Total recorded investment in TDRs	13,474,000		13,760,000
Nonperforming Financing Receivable [Member]
Financing Receivable, Modifications [Line Items]
Total recorded investment in TDRs	$ 1,074,000		$ 2,303,000

Loans Receivable and Allowanc_9

Loans Receivable and Allowance for Loan Losses (Non-Accruing Loans) (Details) - USD ($) $ in Thousands	Mar. 31, 2021	Dec. 31, 2020
Accounts, Notes, Loans and Financing Receivable [Line Items]
Non-accrual loans	$ 14,405	$ 16,396
Originated loans [Member] | Residential [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Non-accrual loans	701	1,736
Originated loans [Member] | Commercial & Multi-family [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Non-accrual loans	7,962	8,721
Originated loans [Member] | Commercial Business [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Non-accrual loans	5,307	5,383
Originated loans [Member] | Home Equity [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Non-accrual loans	$ 435	$ 556

Loans Receivable and Allowan_10

Loans Receivable and Allowance for Loan Losses (Loan Portfolio by Pass Rating) (Details) - USD ($) $ in Thousands	Mar. 31, 2021	Dec. 31, 2020	Mar. 31, 2020
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans receivable, gross	$ 2,333,263	$ 2,330,018	$ 2,190,677
Pass [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans receivable, gross	2,235,899	2,256,702
Special Mention [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans receivable, gross	41,186	4,736
Substandard [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans receivable, gross	56,178	68,580
Residential [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans receivable, gross	234,375	244,369	268,137
Commercial & Multi-family [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans receivable, gross	1,700,113	1,690,836	1,577,816
Construction [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans receivable, gross	167,224	155,967	101,692
Commercial Business [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans receivable, gross	177,340	184,357	177,146
Home Equity [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans receivable, gross	53,360	53,667	64,857
Consumer [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans receivable, gross	851	822	$ 1,029
Originated loans [Member] | Residential [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans receivable, gross	234,375	244,369
Originated loans [Member] | Residential [Member] | Pass [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans receivable, gross	232,669	241,237
Originated loans [Member] | Residential [Member] | Special Mention [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans receivable, gross	724	1,087
Originated loans [Member] | Residential [Member] | Substandard [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans receivable, gross	982	2,045
Originated loans [Member] | Commercial & Multi-family [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans receivable, gross	1,700,113	1,690,836
Originated loans [Member] | Commercial & Multi-family [Member] | Pass [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans receivable, gross	1,622,917	1,631,838
Originated loans [Member] | Commercial & Multi-family [Member] | Special Mention [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans receivable, gross	38,464	2,152
Originated loans [Member] | Commercial & Multi-family [Member] | Substandard [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans receivable, gross	38,732	56,846
Originated loans [Member] | Construction [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans receivable, gross	167,224	155,967
Originated loans [Member] | Construction [Member] | Pass [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans receivable, gross	164,437	155,967
Originated loans [Member] | Construction [Member] | Substandard [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans receivable, gross	2,787
Originated loans [Member] | Commercial Business [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans receivable, gross	177,340	184,357
Originated loans [Member] | Commercial Business [Member] | Pass [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans receivable, gross	162,408	173,833
Originated loans [Member] | Commercial Business [Member] | Special Mention [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans receivable, gross	1,998	1,497
Originated loans [Member] | Commercial Business [Member] | Substandard [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans receivable, gross	12,934	9,027
Originated loans [Member] | Home Equity [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans receivable, gross	53,360	53,667
Originated loans [Member] | Home Equity [Member] | Pass [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans receivable, gross	52,617	53,005
Originated loans [Member] | Home Equity [Member] | Substandard [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans receivable, gross	743	662
Originated loans [Member] | Consumer [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans receivable, gross	851	822
Originated loans [Member] | Consumer [Member] | Pass [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans receivable, gross	$ 851	$ 822

Stockholders' Equity (Narrative

Stockholders' Equity (Narrative) (Details) - USD ($) $ / shares in Units, $ in Thousands	Dec. 15, 2020	Sep. 01, 2020	Aug. 31, 2020	Aug. 10, 2020	Jul. 13, 2020	Mar. 31, 2021	Mar. 31, 2020	Dec. 31, 2020
Stockholders' Equity Note [Line Items]
Preferred stock redeemed, value							$ 140
Series H Preferred Stock [Member]
Stockholders' Equity Note [Line Items]
Preferred stock, dividend rate	3.50%	3.50%			3.50%	3.50%	3.50%	3.50%
Proceeds from issuance of private placement	$ 2,250	$ 5,900			$ 3,100
Shares issued	225	590			308
Series F Preferred Stock [Member]
Stockholders' Equity Note [Line Items]
Preferred stock, dividend rate			6.00%				6.00%
Preferred stock redeemed, shares			6,465
Preferred stock, redemption price			$ 1,000
Preferred stock redeemed, value			$ 6,500
Series C Preferred Stock [Member]
Stockholders' Equity Note [Line Items]
Preferred stock, dividend rate				6.00%			6.00%
Preferred stock redeemed, shares				388
Preferred stock, redemption price				$ 10,000
Preferred stock redeemed, value				$ 3,900
Series G Preferred Stock [Member]
Stockholders' Equity Note [Line Items]
Preferred stock, dividend rate						6.00%	6.00%	6.00%

Bank Owned Life Insurance (Narr

Bank Owned Life Insurance (Narrative) (Details) - USD ($) $ in Thousands	1 Months Ended		3 Months Ended
	Jan. 31, 2021	Aug. 31, 2020	Mar. 31, 2021
Bank Owned Life Insurance [Abstract]
Bank owned life insurance, amount			$ 70,200
Bank owned life insurance, amount purchased	$ 8,500	$ 60,000
Bank-owned Life Insurance ("BOLI") income			$ 701

Goodwill and Other Intangible_2

Goodwill and Other Intangible Assets (Narrative) (Details) - USD ($)	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Impairment of intangible assets	$ 0
Goodwill	$ 5,200,000	$ 5,200,000
Core Deposit Intangibles [Member]
Intangible asset, useful life	10 years
Amortization expense	$ 16,000	18,000
Intangible assets, net	$ 219,000	$ 281,000

Fair Values of Financial Inst_3

Fair Values of Financial Instruments (Narrative) (Details) - USD ($)	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020	Dec. 31, 2020
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Transfers between fair value hierarchy	$ 0	$ 0
Impaired loans	23,613,000		$ 14,591,000
Valuation allowance	5,307,000		4,461,000
Significant Unobservable Inputs (Level 3) [Member] | Impaired Loans [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Impaired loans	23,600,000		14,600,000
Valuation allowance	$ 5,300,000		$ 4,400,000

Fair Values of Financial Inst_4

Fair Values of Financial Instruments (Fair Value Measurements, Recurring) (Details) - USD ($) $ in Thousands	Mar. 31, 2021	Dec. 31, 2020
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt Securities Available for Sale	$ 93,582	$ 99,756
Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt Securities Available for Sale	93,582	99,756
Marketable Equities	18,278	17,717
Total Securities	111,860	117,473
Quoted Prices in Active Markets for Identical Assets (Level 1) [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable Equities	18,278	17,717
Quoted Prices in Active Markets for Identical Assets (Level 1) [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt Securities Available for Sale
Marketable Equities	18,278	17,717
Total Securities	18,278	17,717
Significant Other Observable Inputs (Level 2) [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt Securities Available for Sale	93,582	99,756
Significant Other Observable Inputs (Level 2) [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt Securities Available for Sale	93,582	99,756
Total Securities	93,582	99,756
Significant Unobservable Inputs (Level 3) [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt Securities Available for Sale
Marketable Equities
Total Securities

Fair Values of Financial Inst_5

Fair Values of Financial Instruments (Fair Value Measurements, Nonrecurring) (Details) - USD ($) $ in Thousands	Mar. 31, 2021	Dec. 31, 2020
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Impaired loans	$ 18,306	$ 10,130
Other real estate owned	414	414
Quoted Prices in Active Markets for Identical Assets (Level 1) [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Impaired loans
Other real estate owned
Significant Other Observable Inputs (Level 2) [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Impaired loans
Other real estate owned
Significant Unobservable Inputs (Level 3) [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Impaired loans	18,306	10,130
Other real estate owned	$ 414	$ 414

Fair Values of Financial Inst_6

Fair Values of Financial Instruments (Quantitative Information about Level 3 Fair Value Measurements) (Details) $ in Thousands	Mar. 31, 2021USD ($)item	Dec. 31, 2020USD ($)item
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Impaired Loans | $	$ 18,306	$ 10,130
Other Real Estate Owned | $	414	414
Significant Unobservable Inputs (Level 3) [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Impaired Loans | $	18,306	10,130
Other Real Estate Owned | $	$ 414	$ 414
Significant Unobservable Inputs (Level 3) [Member] | Minimum [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Impaired Loans, Range | item	0	0
Other Real Estate Owned, Range | item	0	0
Significant Unobservable Inputs (Level 3) [Member] | Maximum [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Impaired Loans, Range | item	10	10
Other Real Estate Owned, Range | item	10	10

Fair Values of Financial Inst_7

Fair Values of Financial Instruments (Carrying Values and Estimated Fair Values of Financial Instruments) (Details) - USD ($) $ in Thousands	Mar. 31, 2021	Dec. 31, 2020
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt securities available for sale	$ 93,582	$ 99,756
Carrying Value [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and cash equivalents	296,938	261,229
Interest-earning time deposits	735	735
Debt securities available for sale	93,582	99,756
Equity investments	18,278	17,717
Loans held for sale	1,147	3,530
Loans receivable, net	2,296,434	2,295,021
FHLB of New York stock, at cost	8,920	11,324
Accrued interest receivable	12,056	12,924
Other Real Estate Owned	414
Deposits	2,404,135	2,318,050
Borrowings	133,298	191,161
Subordinated debentures	37,101	37,042
Accrued interest payable	807	1,463
Fair Value [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and cash equivalents	296,938	261,229
Interest-earning time deposits	735	735
Debt securities available for sale	93,582	99,756
Equity investments	18,278	17,717
Loans held for sale	1,147	3,530
Loans receivable, net	2,294,631	2,309,118
FHLB of New York stock, at cost	8,920	11,324
Accrued interest receivable	12,056	12,924
Other Real Estate Owned	414
Deposits	2,408,469	2,323,561
Borrowings	131,806	194,899
Subordinated debentures	36,686	37,252
Accrued interest payable	807	1,463
Quoted Prices in Active Markets for Identical Assets (Level 1) [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and cash equivalents	296,938	261,229
Equity investments	18,278	17,717
Deposits	1,719,149	1,627,871
Significant Other Observable Inputs (Level 2) [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Interest-earning time deposits	735	735
Debt securities available for sale	93,582	99,756
Loans held for sale	1,147	3,530
FHLB of New York stock, at cost	8,920	11,324
Accrued interest receivable	12,056	12,924
Deposits	689,320	695,690
Borrowings	131,806	194,899
Subordinated debentures	36,686	37,252
Accrued interest payable	807	1,463
Significant Unobservable Inputs (Level 3) [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Loans receivable, net	2,294,631	$ 2,309,118
Other Real Estate Owned	$ 414

Subordinated Debt (Narrative) (

Subordinated Debt (Narrative) (Details) - USD ($)	3 Months Ended
	Mar. 31, 2021	Dec. 31, 2020	Jul. 30, 2018
Trust Preferred Securities Subject to Mandatory Redemption [Member]
Subordinated Borrowing [Line Items]
Variable interest rate spread	2.65%
Trust preferred securities	$ 4,124,000
Fixed To Floating Rate Subordinated Debentures [Member]
Subordinated Borrowing [Line Items]
Face amount			$ 33,500,000
Notes term	10 years
Redemption restriction period	5 years
Deferred finance costs	$ 523,000	$ 911,000
Fixed To Floating Rate Subordinated Debentures [Member] | First Five Years [Member]
Subordinated Borrowing [Line Items]
Interest rate	5.625%
Fixed To Floating Rate Subordinated Debentures [Member] | After Five Years [Member]
Subordinated Borrowing [Line Items]
Variable interest rate spread	2.72%

Lease Obligations (Narrative) (

Lease Obligations (Narrative) (Details) - item	3 Months Ended
	Mar. 31, 2021	Dec. 31, 2020
Lessee, Lease, Description [Line Items]
Number of operating leases	28
Weighted average remaining lease term, operating leases	6 years 4 months 24 days	6 years 6 months 25 days
Weighted average discount rate, operating leases	2.65%	2.67%
Minimum [Member]
Lessee, Lease, Description [Line Items]
Remaining lease terms	1 year
Maximum [Member]
Lessee, Lease, Description [Line Items]
Remaining lease terms	12 years

Lease Obligations (Schedule of

Lease Obligations (Schedule of Lease Information) (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020	Dec. 31, 2020
Lease Obligations [Abstract]
Operating lease cost	$ 952	$ 854
Variable lease cost-operating leases	246	202
Operating lease right-of-use assets	14,328	14,988	$ 14,988
Current liabilities	3,020	2,992
Operating lease liabilities (noncurrent portion)	11,569	12,232
Total operating lease liabilities	$ 14,589	$ 15,224	$ 15,224

Lease Obligations (Summary of M

Lease Obligations (Summary of Maturity of Lease Obligations for Operating Leases) (Details) - USD ($) $ in Thousands	Mar. 31, 2021	Dec. 31, 2020	Mar. 31, 2020
Lease Obligations [Abstract]
One year or less	$ 3,358	$ 3,348
Over one year through three years	5,225	5,424
Over three years through five years	3,269	3,459
Over five years	4,065	4,415
Gross Operating Lease Liabilities	15,917	16,646
Deferred Expenses	(1,328)	(1,422)
Total Operating Lease Liabilities	$ 14,589	$ 15,224	$ 15,224

Subsequent Events (Narrative) (

Subsequent Events (Narrative) (Details) - Subsequent Event [Member]	Apr. 14, 2021$ / shares
Subsequent Event [Line Items]
Date declared	Apr. 14, 2021
Dividends per common share	$ 0.14
Date of record	May 10, 2021
Date paid	May 24, 2021